Share

Manns, Michael P. de

List of all publications

Publishing since 1988 (Dinosaur)

    2010

  1. Journal Article Jaroszewicz J, Serrano BC, Wursthorn K, Deterding K, Schlue J, Raupach R, Flisiak R, Bock CT, Manns MP, Wedemeyer H, Cornberg M. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.  J. Hepatol.  2010;52;4  Link to Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.
  2. English AbstractJournal Article Mederacke I, Wursthorn K, Ho H, Manns MP, Wedemeyer H. [Interferon-alfa induced reactivation of sarcoidosis in a patient with chronic hepatitis C]  Internist (Berl)  2010;51;4  Link to [Interferon-alfa induced reactivation of sarcoidosis in a patient with chronic hepatitis C]
  3. Journal Article Erichsen TJ, Aehlen A, Ehmer U, Kalthoff S, Manns MP, Strassburg CP. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.  J. Hepatol.  2010;52;4  Link to Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
  4. Journal Article Tillmann HL, Wiese M, Braun Y, Weigand J, Tenckhoff S, Mössner J, Manns MP, Weissenborn K. Quality of life in patients with various liver diseases.  J. Viral Hepat.  2010  Link to Quality of life in patients with various liver diseases.
  5. Journal Article Brandt D, Volkmann X, Anstätt M, Länger F, Manns MP, Schulze-Osthoff K, Bantel H. Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomas.  Eur. J. Cancer  2010  Link to Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomas.
  6. Journal Article Dintsios CM, Haverkamp A, Wiegand J, Gerlach T, Wedemeyer H, Pape G, Manns MP, Krauth C. Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany.  Eur J Gastroenterol Hepatol  2010;22;3  Link to Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany.
  7. Journal ArticleMeta-AnalysisMulticenter Study Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, Lie BA, Bergquist A, Schramm C, Weismüller TJ, Gotthardt D, Rust C, Philipp EE, Fritz T, Henckaerts L, Weersma RK, Stokkers P, Ponsioen CY, Wijmenga C, Sterneck M, Nothnagel M, Hampe J, Teufel A, Runz H, Rosenstiel P, Stiehl A, Vermeire S, Beuers U, Manns MP, Schrumpf E, Boberg KM, Schreiber S. Genome-wide association analysis in primary sclerosing cholangitis.  Gastroenterology  2010;138;3  Link to Genome-wide association analysis in primary sclerosing cholangitis.
  8. Introductory Journal Article Manns MP, Hochberger J, Welte T. ["Gastro meets Pneumo": two conventions--one concern]  Internist (Berl)  2010;51 Suppl 1  Link to ["Gastro meets Pneumo": two conventions--one concern]
  9. Journal Article Ciesek S, Steinmann E, Iken M, Ott M, Helfritz FA, Wappler I, Manns MP, Wedemeyer H, Pietschmann T. Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus.  Gastroenterology  2010  Link to Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus.
  10. Journal Article Pischke S, Tutarel O, Greten TF, Heim A, Wedemeyer J, Herzog P, Saddekni N, Barg-Hock H, Strassburg C, Manns MP, Rifai K, Gebel M. CMV-Enterocolitis as a Cause for Repeated Intestinal Intussusceptions in an Adult Patient after Liver Transplantation?  Z Gastroenterol  2010  Link to CMV-Enterocolitis as a Cause for Repeated Intestinal Intussusceptions in an Adult Patient after Liver Transplantation?
  11. Journal Article Stegmann KA, Björkström NK, Liermann H, Ciesek S, Riese P, Wiegand J, Hadem J, Suneetha PV, Jaroszewicz J, Wang C, Schlaphoff V, Fytili P, Cornberg M, Manns MP, Geffers R, Pietschmann T, Guzmán CA, Ljunggren HG, Wedemeyer H. Interferon-Alfa-Induced Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection.  Gastroenterology  2010  Link to Interferon-Alfa-Induced Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection.
  12. Journal Article Sarrazin C, Berg T, Ross RS, Schirmacher P, Wedemeyer H, Neumann U, Schmidt HH, Spengler U, Wirth S, Kessler HH, Peck-Radosavljevic M, Ferenci P, Vogel W, Moradpour D, Heim M, Cornberg M, Protzer U, Manns MP, Fleig WE, Dollinger MM, Zeuzem S. [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]  Z Gastroenterol  2010;48;2  Link to [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]
  13. Journal Article Stange MA, Tutarel O, Pischke S, Schneider A, Strassburg CP, Becker T, Barg-Hock H, Bastürk M, Wursthorn K, Cornberg M, Ott M, Greten TF, Manns MP, Wedemeyer H. Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.  Z Gastroenterol  2010;48;2  Link to Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.
  14. Journal Article Volkmann M, Luithle D, Zentgraf H, Schnölzer M, Fiedler S, Heid H, Schulze-Bergkamen A, Strassburg CP, Gehrke SG, Manns MP. SLA/LP/tRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract.  J. Autoimmun.  2010;34;1  Link to SLA/LP/tRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract.
  15. Journal Article Greten TF, Ormandy LA, Fikuart A, Höchst B, Henschen S, Hörning M, Manns MP, Korangy F. Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC.  J. Immunother.  2010;33;2  Link to Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC.
  16. Journal Article Heringlake S, Hofdmann M, Fiebeler A, Manns MP, Schmiegel W, Tannapfel A. Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.  J. Hepatol.  2010;52;2  Link to Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.
  17. Journal Article Wedemeyer J, Brangewitz M, Kubicka S, Jackobs S, Winkler M, Neipp M, Klempnauer J, Manns MP, Schneider AS. Management of major postsurgical gastroesophageal intrathoracic leaks with an endoscopic vacuum-assisted closure system.  Gastrointest. Endosc.  2010;71;2  Link to Management of major postsurgical gastroesophageal intrathoracic leaks with an endoscopic vacuum-assisted closure system.
  18. Journal Article Pischke S, Ehmer U, Schedel I, Gratz WF, Wedemeyer H, Ziesing S, Bange FC, Burchard GD, Manns MP, Bahr MJ, Strassburg CP. Of guinea pigs and men--an unusual case of jaundice.  Z Gastroenterol  2010;48;1  Link to Of guinea pigs and men--an unusual case of jaundice.
  19. Journal ArticleReview Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.  Nat Rev Gastroenterol Hepatol  2010;7;1  Link to Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.
  20. Journal Article Ciesek S, Rifai K, Bahr MJ, Boozari B, Steinmann E, Helfritz FA, Wedemeyer H, Manns MP, Gebel M. Membranous Budd-Chiari syndrome in Caucasians.  Scand. J. Gastroenterol.  2010;45;2  Link to Membranous Budd-Chiari syndrome in Caucasians.
  21. Case ReportsJournal Article Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, Schlue J, Strassburg CP, Lehner F, Raupach R, Bremer B, Magerstedt P, Cornberg M, Seehusen F, Baumgaertner W, Klempnauer J, Izopet J, Manns MP, Grummer B, Wedemeyer H. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.  Liver Transpl.  2010;16;1  Link to Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.
  22. English AbstractJournal ArticleReview Cornberg M, Manns MP. [Entecavir - options and obstacles of an effective treatment for chronic hepatitis B]  Dtsch. Med. Wochenschr.  2010;135;1-2  Link to [Entecavir - options and obstacles of an effective treatment for chronic hepatitis B]
  23. Case ReportsLetter Tutarel O, Barg-Hock H, Pischke S, Bahr MJ, Kreipe HH, Greten TF, Manns MP, Strassburg CP. Mycosis fungoides with involvement of the larynx after liver transplantation in an adult.  Am. J. Gastroenterol.  2010;105;1  Link to Mycosis fungoides with involvement of the larynx after liver transplantation in an adult.

    24. 2009

  24. Journal Article Wang C, Heim A, Schlaphoff V, Suneetha PV, Stegmann KA, Jiang H, Krueger M, Fytili P, Schulz T, Cornberg M, Kandolf R, Manns MP, Bock CT, Wedemeyer H. Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.  J. Med. Virol.  2009;81;12  Link to Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.
  25. Comparative StudyJournal Article Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H. Virological and clinical characteristics of delta hepatitis in Central Europe.  J. Viral Hepat.  2009;16;12  Link to Virological and clinical characteristics of delta hepatitis in Central Europe.
  26. Journal ArticleReview Dieterich DT, Rizzetto M, Manns MP. Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin.  J. Viral Hepat.  2009;16;12  Link to Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin.
  27. Journal ArticleResearch Support, N.I.H., Extramural Yu H, Riederer B, Stieger N, Boron WF, Shull GE, Manns MP, Seidler UE, Bachmann O. Secretagogue stimulation enhances NBCe1 (electrogenic Na(+)/HCO(3)(-) cotransporter) surface expression in murine colonic crypts.  Am. J. Physiol. Gastrointest. Liver Physiol.  2009;297;6  Link to Secretagogue stimulation enhances NBCe1 (electrogenic Na(+)/HCO(3)(-) cotransporter) surface expression in murine colonic crypts.
  28. Evaluation StudiesJournal Article Petersen C, Meier PN, Schneider A, Turowski C, Pfister ED, Manns MP, Ure BM, Wedemeyer J. Endoscopic retrograde cholangiopancreaticography prior to explorative laparotomy avoids unnecessary surgery in patients suspected for biliary atresia.  J. Hepatol.  2009;51;6  Link to Endoscopic retrograde cholangiopancreaticography prior to explorative laparotomy avoids unnecessary surgery in patients suspected for biliary atresia.
  29. Journal Article Pischke S, Ho H, Urbanek F, Meyer-Olsen D, Suneetha PV, Manns MP, Stoll M, Wedemeyer H. Hepatitis E in HIV-positive patients in a low-endemic country.  J. Viral Hepat.  2009  Link to Hepatitis E in HIV-positive patients in a low-endemic country.
  30. Journal Article Wiegand J, Meya S, Schlaphoff V, Manns MP, Mössner J, Wedemeyer H, Tillmann HL. HBV-specific T-cell responses in healthy seronegative sexual partners of patients with chronic HBV infection.  J. Viral Hepat.  2009  Link to HBV-specific T-cell responses in healthy seronegative sexual partners of patients with chronic HBV infection.
  31. Journal Article Ciesek S, Steinmann E, Wedemeyer H, Manns MP, Neyts J, Tautz N, Madan V, Bartenschlager R, von Hahn T, Pietschmann T. Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.  Hepatology  2009;50;5  Link to Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.
  32. Journal Article Mederacke I, Wedemeyer H, Ciesek S, Steinmann E, Raupach R, Wursthorn K, Manns MP, Tillmann HL. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay.  J. Clin. Virol.  2009;46;3  Link to Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay.
  33. Journal Article Mederacke I, Wursthorn K, Kirschner J, Rifai K, Manns MP, Wedemeyer H, Bahr MJ. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection.  Liver Int.  2009;29;10  Link to Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection.
  34. Journal ArticleResearch Support, N.I.H., Extramural Schüngel S, Buitrago-Molina LE, Nalapareddy P, Lebofsky M, Manns MP, Jaeschke H, Gross A, Vogel A. The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers.  Hepatology  2009;50;5  Link to The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers.
  35. Journal Article Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, Cakaloglu Y, Degertekin H, Gurel S, Zeuzem S, Bozkaya H, Schlaphoff V, Dienes HP, Bock TC, Manns MP, Wedemeyer H. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.  Liver Int.  2009  Link to Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.
  36. Journal Article Rifai K, Das A, Rosenau J, Ernst T, Kretschmer U, Haller H, Fliser D, Manns MP. Changes in Plasma Amino Acids During Extracorporeal Liver Support by Fractionated Plasma Separation and Adsorption.  Artif Organs  2009  Link to Changes in Plasma Amino Acids During Extracorporeal Liver Support by Fractionated Plasma Separation and Adsorption.
  37. Journal Article Haridass D, Yuan Q, Becker PD, Cantz T, Iken M, Rothe M, Narain N, Bock M, Nörder M, Legrand N, Wedemeyer H, Weijer K, Spits H, Manns MP, Cai J, Deng H, Di Santo JP, Guzman CA, Ott M. Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice.  Am. J. Pathol.  2009;175;4  Link to Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice.
  38. Journal Article Weismüller TJ, Negm A, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.  Transpl. Int.  2009;22;10  Link to The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
  39. BiographyHistorical ArticleJournal ArticlePortraits Manns MP. EASL Recognition Awardee 2009: Prof. Daniel Shouval.  J. Hepatol.  2009;51;4  Link to EASL Recognition Awardee 2009: Prof. Daniel Shouval.
  40. Journal Article Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, Lehner F, Manns MP, Greten TF, Korangy F. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.  Hepatology  2009;50;3  Link to Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.
  41. Journal Article Zhao F, Obermann S, von Wasielewski R, Haile L, Manns MP, Korangy F, Greten TF. Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma.  Immunology  2009;128;1  Link to Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma.
  42. Journal Article Zhao F, Vermeer B, Lehmann U, Kreipe H, Manns MP, Korangy F, Greten TF. Identification of a novel murine pancreatic tumour antigen, which elicits antibody responses in patients with pancreatic carcinoma.  Immunology  2009;128;1  Link to Identification of a novel murine pancreatic tumour antigen, which elicits antibody responses in patients with pancreatic carcinoma.
  43. Journal ArticleResearch Support, N.I.H., Extramural Nalapareddy P, Schüngel S, Hong JY, Manns MP, Jaeschke H, Vogel A. The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis.  Am. J. Pathol.  2009;175;3  Link to The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis.
  44. Clinical Trial, Phase IIJournal ArticleMulticenter Study Wedemeyer H, Schuller E, Schlaphoff V, Stauber RE, Wiegand J, Schiefke I, Firbas C, Jilma B, Thursz M, Zeuzem S, Hofmann WP, Hinrichsen H, Tauber E, Manns MP, Klade CS. Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.  Vaccine  2009;27;37  Link to Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
  45. Journal Article Krisper P, Tiran B, Fliser D, Haditsch B, Stadlbauer V, Otto R, Ernst T, Kretschmer U, Stauber RE, Haller H, Holzer H, Manns MP, Rifai K. Efficacy and Safety of Anticoagulation With Heparin Versus Heparin Plus Epoprostenol in Patients Undergoing Extracorporeal Liver Support With Prometheus.  Artif Organs  2009  Link to Efficacy and Safety of Anticoagulation With Heparin Versus Heparin Plus Epoprostenol in Patients Undergoing Extracorporeal Liver Support With Prometheus.
  46. Introductory Journal Article Manns MP, Vergani D. Autoimmune hepatitis.  Semin. Liver Dis.  2009;29;3  Link to Autoimmune hepatitis.
  47. Journal ArticleReview Strassburg CP, Manns MP. Treatment of autoimmune hepatitis.  Semin. Liver Dis.  2009;29;3  Link to Treatment of autoimmune hepatitis.
  48. Journal Article Buitrago-Molina LE, Pothiraju D, Lamlé J, Marhenke S, Kossatz U, Breuhahn K, Manns MP, Malek N, Vogel A. Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage.  Hepatology  2009;50;2  Link to Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage.
  49. CommentLetter Vogel M, Deterding K, Wiegand J, Grüner NH, Baumgarten A, Jung MC, Manns MP, Wedemeyer H, Rockstroh JK. Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection.  Clin. Infect. Dis.  2009;49;2  Link to Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection.
  50. Journal Article Deterding K, Grüngreiff K, Lankisch TO, Potthoff A, Bahr MJ, Manns MP, Wedemeyer H, Strassburg CP. Gilbert's syndrome and antiviral therapy of hepatitis C.  Ann Hepatol  2009;8;3  Link to Gilbert's syndrome and antiviral therapy of hepatitis C.
  51. Interview Manns MP. [Widespread and mostly unrecognized: chronic hepatitis B: the silent epidemic (interview by Maria Weiss)]  MMW Fortschr Med  2009;151;21  Link to [Widespread and mostly unrecognized: chronic hepatitis B: the silent epidemic (interview by Maria Weiss)]
  52. Journal Article Klade CS, Kubitschke A, Stauber RE, Meyer MF, Zinke S, Wiegand J, Zauner W, Aslan N, Lehmann M, Cornberg M, Manns MP, Reisner P, Wedemeyer H. Hepatitis C virus-specific T cell responses against conserved regions in recovered patients.  Vaccine  2009;27;23  Link to Hepatitis C virus-specific T cell responses against conserved regions in recovered patients.
  53. Journal Article Heringlake S, Schütte A, Flemming P, Schmiegel W, Manns MP, Tillmann HL. Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.  Z Gastroenterol  2009;47;5  Link to Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.
  54. English AbstractJournal ArticleReview Strassburg CP, Manns MP. [Liver transplantation: indications and results]  Internist (Berl)  2009;50;5  Link to [Liver transplantation: indications and results]
  55. Introductory Journal Article Strassburg CP, Manns MP. [Transplantation medicine 2009]  Internist (Berl)  2009;50;5  Link to [Transplantation medicine 2009]
  56. Case ReportsLetter Aigner E, Strassburg CP, Strasser M, Pohla-Gubo G, Dietze O, Hutter J, Manns MP, Datz C. Transient autoimmune hepatitis induced by a thymoma.  Am. J. Gastroenterol.  2009;104;5  Link to Transient autoimmune hepatitis induced by a thymoma.
  57. Journal Article Lankisch TO, Behrens G, Ehmer U, Möbius U, Rockstroh J, Wehmeier M, Kalthoff S, Freiberg N, Manns MP, Schmidt RE, Strassburg CP. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment.  J. Hepatol.  2009;50;5  Link to Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment.
  58. Case ReportsJournal Article Deterding K, Pothakamuri SV, Schlaphoff V, Hadem J, Metzler F, Bahr MJ, Manns MP, Cornberg M, Wedemeyer H. Clearance of chronic HCV infection during acute delta hepatitis.  Infection  2009;37;2  Link to Clearance of chronic HCV infection during acute delta hepatitis.
  59. Journal Article Suneetha PV, Schlaphoff V, Wang C, Stegmann KA, Fytili P, Sarin SK, Manns MP, Cornberg M, Wedemeyer H. Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.  J. Immunol. Methods  2009;342;1-2  Link to Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.
  60. Journal Article Ramakrishna E, Woller N, Mundt B, Knocke S, Gürlevik E, Saborowski M, Malek N, Manns MP, Wirth T, Kühnel F, Kubicka S. Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.  Cancer Res.  2009;69;4  Link to Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.
  61. Journal ArticleReview Zeuzem S, Berg T, Moeller B, Hinrichsen H, Mauss S, Wedemeyer H, Sarrazin C, Hueppe D, Zehnter E, Manns MP. Expert opinion on the treatment of patients with chronic hepatitis C.  J. Viral Hepat.  2009;16;2  Link to Expert opinion on the treatment of patients with chronic hepatitis C.
  62. Journal ArticleReview Mederacke I, Wedemeyer H, Manns MP. Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection.  Curr Opin Investig Drugs  2009;10;2  Link to Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection.
  63. Journal Article de Boer JF, Bahr MJ, Böker KH, Manns MP, Tietge UJ. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.  Am. J. Physiol. Gastrointest. Liver Physiol.  2009;296;2  Link to Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
  64. Journal ArticleReview Greten TF, Korangy F, Manns MP, Malek NP. Molecular therapy for the treatment of hepatocellular carcinoma.  Br. J. Cancer  2009;100;1  Link to Molecular therapy for the treatment of hepatocellular carcinoma.
  65. Journal Article Beckmann MG, Bahr MJ, Hadem J, Bredt M, Wedemeyer H, Schneider AS, Kubicka S, Manns MP, Strassburg CP, Wedemeyer J. Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy.  Gastroenterol Res Pract  2009;2009  Link to Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy.
  66. Comparative StudyJournal Article Potthoff A, Witte T, Rifai K, Hoy L, Deterding K, Feyerabend S, Manns MP, Wedemeyer H. Prevalence of alpha-fodrin antibodies in patients with chronic hepatitis C infection and Sjögren syndrome.  Scand. J. Gastroenterol.  2009;44;8  Link to Prevalence of alpha-fodrin antibodies in patients with chronic hepatitis C infection and Sjögren syndrome.
  67. English AbstractJournal ArticleReview Greten TF, Manns MP, Malek N. [Sorafenib for the treatment of HCC--the beginning of a new era in the treatment of HCC]  Z Gastroenterol  2009;47;1  Link to [Sorafenib for the treatment of HCC--the beginning of a new era in the treatment of HCC]
  68. Journal Article Bahr MJ, Boeker KH, Manns MP, Tietge UJ. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.  Clin. Endocrinol. (Oxf)  2009;70;1  Link to Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.

    69. 2008

  69. Controlled Clinical TrialJournal ArticleMulticenter Study Potthoff A, Wedemeyer H, Boecher WO, Berg T, Zeuzem S, Arnold J, Spengler U, Gruengreiff K, Kaeser T, Schuchmann M, Bergk A, Forestier N, Deterding K, Manns MP, Trautwein C. The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.  J. Hepatol.  2008;49;5  Link to The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.
  70. Case ReportsCommentLetter Deterding K, Manns MP, Wedemeyer H. Does the presence of adefovir-resistant variants lead to failure of tenofovir monotherapy?  J. Hepatol.  2008;49;5  Link to Does the presence of adefovir-resistant variants lead to failure of tenofovir monotherapy?
  71. CommentLetter Ciesek S, Steinmann E, Manns MP, Wedemeyer H, Pietschmann T. The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase.  J. Infect. Dis.  2008;198;7  Link to The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase.
  72. Journal ArticleMulticenter Study Deterding K, Constantinescu I, Nedelcu FD, Gervain J, Nemecek V, Srtunecky O, Vince A, Grgurevic I, Bielawski KP, Zalewska M, Bock T, Ambrozaitis A, Stanczak J, Takács M, Chulanov V, Slusarczyk J, Drazd'áková M, Wiegand J, Cornberg M, Manns MP, Wedemeyer H. Prevalence of HBV genotypes in Central and Eastern Europe.  J. Med. Virol.  2008;80;10  Link to Prevalence of HBV genotypes in Central and Eastern Europe.
  73. Case ReportsEnglish AbstractJournal Article Ciesek S, Kirchhoff T, Niehaus M, Manns MP, Greten TF. [Suspicion of a newly appearing hypertrophic obstructive cardiomyopathy in a patient treated for hepatocellular carcinoma]  Dtsch. Med. Wochenschr.  2008;133;43  Link to [Suspicion of a newly appearing hypertrophic obstructive cardiomyopathy in a patient treated for hepatocellular carcinoma]
  74. Journal Article Boozari B, Bahr MJ, Kubicka S, Klempnauer J, Manns MP, Gebel M. Ultrasonography in patients with Budd-Chiari syndrome: diagnostic signs and prognostic implications.  J. Hepatol.  2008;49;4  Link to Ultrasonography in patients with Budd-Chiari syndrome: diagnostic signs and prognostic implications.
  75. Case ReportsJournal Article Hadem J, Cornberg M, Hauptmann C, Süttmann U, Manns MP, Wedemeyer H. Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - do not miss vaccination before starting therapy.  Z Gastroenterol  2008;46;9  Link to Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - do not miss vaccination before starting therapy.
  76. Journal Article Lankisch TO, Gillman TC, Erichsen TJ, Ehmer U, Kalthoff S, Freiberg N, Munzel PA, Manns MP, Strassburg CP. Aryl hydrocarbon receptor-mediated regulation of the human estrogen and bile acid UDP-glucuronosyltransferase 1A3 gene.  Arch. Toxicol.  2008;82;9  Link to Aryl hydrocarbon receptor-mediated regulation of the human estrogen and bile acid UDP-glucuronosyltransferase 1A3 gene.
  77. Journal ArticleReview Greten TF, Manns MP. [Hepatocellular carcinoma - diagnosis and treatment]  Dtsch. Med. Wochenschr.  2008;133;38  Link to [Hepatocellular carcinoma - diagnosis and treatment]
  78. Journal Article Haile LA, von Wasielewski R, Gamrekelashvili J, Krüger C, Bachmann O, Westendorf AM, Buer J, Liblau R, Manns MP, Korangy F, Greten TF. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.  Gastroenterology  2008;135;3  Link to Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
  79. Case ReportsJournal Article Lankisch TO, Manns MP, Wedemeyer J. Why men should not iron: unperceived swallowed dental root instrument causes seven years of abdominal pain.  Clin. Gastroenterol. Hepatol.  2008;6;9  Link to Why men should not iron: unperceived swallowed dental root instrument causes seven years of abdominal pain.
  80. Journal Article Jiang H, Schiffer E, Song Z, Wang J, Zürbig P, Thedieck K, Moes S, Bantel H, Saal N, Jantos J, Brecht M, Jenö P, Hall MN, Hager K, Manns MP, Hecker H, Ganser A, Döhner K, Bartke A, Meissner C, Mischak H, Ju Z, Rudolph KL. Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease.  Proc. Natl. Acad. Sci. U.S.A.  2008;105;32  Link to Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease.
  81. Journal ArticlePractice Guideline Cornberg M, Protzer U, Dollinger MM, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns MP. The German guideline for the management of hepatitis B virus infection: short version.  J. Viral Hepat.  2008;15 Suppl 1  Link to The German guideline for the management of hepatitis B virus infection: short version.
  82. CommentLetter Suneetha PV, Mederacke I, Heim A, Bastürk M, Cornberg M, Strassburg CP, Manns MP, Wedemeyer H. Spontaneous clearance of chronic hepatitis C after liver transplantation: are hepatitis C virus-specific T cell responses the clue?  Liver Transpl.  2008;14;8  Link to Spontaneous clearance of chronic hepatitis C after liver transplantation: are hepatitis C virus-specific T cell responses the clue?
  83. Journal Article Marhenke S, Lamlé J, Buitrago-Molina LE, Cañón JM, Geffers R, Finegold M, Sporn M, Yamamoto M, Manns MP, Grompe M, Vogel A. Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development.  Hepatology  2008;48;2  Link to Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development.
  84. Journal Article Schwettmann L, Wehmeier M, Jokovic D, Aleksandrova K, Brand K, Manns MP, Lichtinghagen R, Bahr MJ. Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases.  J. Hepatol.  2008;49;2  Link to Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases.
  85. Journal Article Singh AK, Sjöblom M, Zheng W, Krabbenhöft A, Riederer B, Rausch B, Manns MP, Soleimani M, Seidler U. CFTR and its key role in in vivo resting and luminal acid-induced duodenal HCO3- secretion.  Acta Physiol (Oxf)  2008;193;4  Link to CFTR and its key role in in vivo resting and luminal acid-induced duodenal HCO3- secretion.
  86. Journal Article Fytili P, Dalekos GN, Schlaphoff V, Suneetha PV, Sarrazin C, Zauner W, Zachou K, Berg T, Manns MP, Klade CS, Cornberg M, Wedemeyer H. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.  Vaccine  2008;26;31  Link to Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
  87. Journal Article Erichsen TJ, Ehmer U, Kalthoff S, Lankisch TO, Müller TM, Munzel PA, Manns MP, Strassburg CP. Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene.  Toxicol. Appl. Pharmacol.  2008;230;2  Link to Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene.
  88. Journal Article Nickeleit I, Zender S, Sasse F, Geffers R, Brandes G, Sörensen I, Steinmetz H, Kubicka S, Carlomagno T, Menche D, Gütgemann I, Buer J, Gossler A, Manns MP, Kalesse M, Frank R, Malek NP. Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition.  Cancer Cell  2008;14;1  Link to Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition.
  89. Journal Article Kaiser T, Damerow HC, Tenckhoff S, Finger A, Böttcher I, Hafer C, Schwarz A, Lüth JB, Schmidt Gürtler H, Colucci G, Manns MP, Wedemeyer H, Tillmann HL. Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis.  J. Med. Virol.  2008;80;7  Link to Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis.
  90. Journal ArticleReview Strassburg CP, Lankisch TO, Manns MP, Ehmer U. Family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A): from Gilbert's syndrome to genetic organization and variability.  Arch. Toxicol.  2008;82;7  Link to Family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A): from Gilbert's syndrome to genetic organization and variability.
  91. Journal Article Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Krüger C, Manns MP, Greten TF, Korangy F. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.  Gastroenterology  2008;135;1  Link to A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.
  92. Journal Article Hadem J, Boozari B, Manns MP, Gebel MJ. [Peritoneal cavity fluid as an unexpected ultrasonographic finding]  MMW Fortschr Med  2008;150;24  Link to [Peritoneal cavity fluid as an unexpected ultrasonographic finding]
  93. Journal ArticleResearch Support, N.I.H., Extramural Holdener M, Hintermann E, Bayer M, Rhode A, Rodrigo E, Hintereder G, Johnson EF, Gonzalez FJ, Pfeilschifter J, Manns MP, Herrath MG, Christen U. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.  J. Exp. Med.  2008;205;6  Link to Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.
  94. Journal Article Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.  Hepatology  2008;47;6  Link to Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
  95. Clinical Trial, Phase IIComparative StudyJournal ArticleRandomized Controlled Trial Klade CS, Wedemeyer H, Berg T, Hinrichsen H, Cholewinska G, Zeuzem S, Blum H, Buschle M, Jelovcan S, Buerger V, Tauber E, Frisch J, Manns MP. Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.  Gastroenterology  2008;134;5  Link to Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
  96. Case ReportsEnglish AbstractJournal Article Girke J, Wedemeyer H, Wiegand J, Manns MP, Tillmann HL. [Acute hepatitis B: is antiviral therapy indicated? Two case reports]  Dtsch. Med. Wochenschr.  2008;133;22  Link to [Acute hepatitis B: is antiviral therapy indicated? Two case reports]
  97. Journal Article Volkmann X, Anstaett M, Hadem J, Stiefel P, Bahr MJ, Lehner F, Manns MP, Schulze-Osthoff K, Bantel H. Caspase activation is associated with spontaneous recovery from acute liver failure.  Hepatology  2008;47;5  Link to Caspase activation is associated with spontaneous recovery from acute liver failure.
  98. Journal Article Hooman N, Rifai K, Hadem J, Vaske B, Philipp G, Priess A, Klempnauer J, Tillmann HL, Manns MP, Rosenau J. Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation.  Liver Transpl.  2008;14;4  Link to Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation.
  99. Comparative StudyJournal Article Lamlé J, Marhenke S, Borlak J, von Wasielewski R, Eriksson CJ, Geffers R, Manns MP, Yamamoto M, Vogel A. Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury.  Gastroenterology  2008;134;4  Link to Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury.
  100. Case ReportsJournal Article Wedemeyer J, Schneider A, Manns MP, Jackobs S. Endoscopic vacuum-assisted closure of upper intestinal anastomotic leaks.  Gastrointest. Endosc.  2008;67;4  Link to Endoscopic vacuum-assisted closure of upper intestinal anastomotic leaks.
  101. Comparative StudyJournal Article Hadem J, Stiefel P, Bahr MJ, Tillmann HL, Rifai K, Klempnauer J, Wedemeyer H, Manns MP, Schneider AS. Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure.  Clin. Gastroenterol. Hepatol.  2008;6;3  Link to Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure.
  102. Journal Article Ciesek S, Liermann H, Hadem J, Greten T, Tillmann HL, Cornberg M, Aslan N, Manns MP, Wedemeyer H. Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.  J. Viral Hepat.  2008;15;3  Link to Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
  103. English AbstractJournal ArticleReview Pischke S, Cornberg M, Manns MP. [Hepatitis associated cryoglobulinemia]  Internist (Berl)  2008;49;3  Link to [Hepatitis associated cryoglobulinemia]
  104. Journal Article Lankisch TO, Schulz C, Zwingers T, Erichsen TJ, Manns MP, Heinemann V, Strassburg CP. Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk.  Cancer Epidemiol. Biomarkers Prev.  2008;17;3  Link to Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk.
  105. Journal Article Gross WL, Manns MP. [Early stages of rheumatic diseases]  Internist (Berl)  2008;49;3  Link to [Early stages of rheumatic diseases]
  106. Journal Article Grannas G, Neipp M, Hoeper MM, Gottlieb J, Lück R, Becker T, Simon A, Strassburg CP, Manns MP, Welte T, Haverich A, Klempnauer J, Nashan B, Strueber M. Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases.  Transplantation  2008;85;4  Link to Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases.
  107. Journal Article Ciesek S, Helfritz FA, Lehmann U, Becker T, Strassburg CP, Neipp M, Ciner A, Fytili P, Tillmann HL, Manns MP, Wedemeyer H. Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver.  J. Infect. Dis.  2008;197;3  Link to Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver.
  108. Journal ArticleReview Wursthorn K, Manns MP, Wedemeyer H. Natural history: the importance of viral load, liver damage and HCC.  Best Pract Res Clin Gastroenterol  2008;22;6  Link to Natural history: the importance of viral load, liver damage and HCC.
  109. Journal Article Wiegand J, Wedemeyer H, Finger A, Heidrich B, Rosenau J, Michel G, Bock CT, Manns MP, Tillmann HL. A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.  Antivir. Ther. (Lond.)  2008;13;4  Link to A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
  110. Journal Article Weismüller TJ, Prokein J, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP. Prediction of survival after liver transplantation by pre-transplant parameters.  Scand. J. Gastroenterol.  2008;43;6  Link to Prediction of survival after liver transplantation by pre-transplant parameters.
  111. Journal ArticleReview Weismüller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.  J. Hepatol.  2008;48 Suppl 1  Link to The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
  112. Journal Article Kirchner GI, Tischendorf JJ, Bleck J, Wagner S, Caselitz M, Klempnauer J, Manns MP, Gebel M. Perihilar lymph nodes in patients with primary sclerosing cholangitis with and without cholangiocellular carcinoma.  Scand. J. Gastroenterol.  2008;43;11  Link to Perihilar lymph nodes in patients with primary sclerosing cholangitis with and without cholangiocellular carcinoma.
  113. Journal Article Sharma AD, Cantz T, Vogel A, Schambach A, Haridass D, Iken M, Bleidissel M, Manns MP, Schöler HR, Ott M. Murine embryonic stem cell-derived hepatic progenitor cells engraft in recipient livers with limited capacity of liver tissue formation.  Cell Transplant  2008;17;3  Link to Murine embryonic stem cell-derived hepatic progenitor cells engraft in recipient livers with limited capacity of liver tissue formation.
  114. Journal ArticleReview Greten TF, Manns MP, Korangy F. Immunotherapy of HCC.  Reviews on recent clinical trials  2008;3;1  Link to Immunotherapy of HCC.
  115. In VitroJournal ArticleResearch Support, N.I.H., Extramural Seidler U, Rottinghaus I, Hillesheim J, Chen M, Riederer B, Krabbenhöft A, Engelhardt R, Wiemann M, Wang Z, Barone S, Manns MP, Soleimani M. Sodium and chloride absorptive defects in the small intestine in Slc26a6 null mice.  Pflugers Arch.  2008;455;4  Link to Sodium and chloride absorptive defects in the small intestine in Slc26a6 null mice.

    116. 2007

  116. Journal ArticleReview Manns MP, Foster GR, Rockstroh JK, Zeuzem S, Zoulim F, Houghton M. The way forward in HCV treatment--finding the right path.  Nat Rev Drug Discov  2007;6;12  Link to The way forward in HCV treatment--finding the right path.
  117. Journal ArticlePractice Guideline Cornberg M, Protzer U, Dollinger MM, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns MP. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.  Z Gastroenterol  2007;45;12  Link to Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.
  118. Comparative StudyJournal ArticleReview Ciesek S, Manns MP, Wedemeyer H. Viral hepatitis after liver transplantation. Which immunosuppressive drugs should be recommended?  Minerva Gastroenterol Dietol  2007;53;4  Link to Viral hepatitis after liver transplantation. Which immunosuppressive drugs should be recommended?
  119. Comparative StudyJournal Article Tacke F, Gäbele E, Bataille F, Schwabe RF, Hellerbrand C, Klebl F, Straub RH, Luedde T, Manns MP, Trautwein C, Brenner DA, Schölmerich J, Schnabl B. Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells.  Dig. Dis. Sci.  2007;52;12  Link to Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells.
  120. Journal ArticleMulticenter Study Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.  Ann. Intern. Med.  2007;147;10  Link to Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.
  121. In VitroJournal Article Volkmann X, Fischer U, Bahr MJ, Ott M, Lehner F, Macfarlane M, Cohen GM, Manns MP, Schulze-Osthoff K, Bantel H. Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver.  Hepatology  2007;46;5  Link to Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver.
  122. Case ReportsJournal Article Potthoff A, Deterding K, Trautwein C, Rifai K, Manns MP, Wedemeyer H. Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.  Eur J Gastroenterol Hepatol  2007;19;10  Link to Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.
  123. English AbstractJournal ArticleReview Kubitschke A, Bader C, Tillmann HL, Manns MP, Kuhn S, Wedemeyer H. [Injuries from needles contaminated with hepatitis C virus: how high is the risk of seroconversion for medical personnel really?]  Internist (Berl)  2007;48;10  Link to [Injuries from needles contaminated with hepatitis C virus: how high is the risk of seroconversion for medical personnel really?]
  124. English AbstractJournal Article Schneider A, Momma M, Manns MP. [Indication for artificial nutrition: enteral and parenteral nutrition]  Internist (Berl)  2007;48;10  Link to [Indication for artificial nutrition: enteral and parenteral nutrition]
  125. Controlled Clinical TrialJournal Article Schlaphoff V, Klade CS, Jilma B, Jelovcan SB, Cornberg M, Tauber E, Manns MP, Wedemeyer H. Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.  Vaccine  2007;25;37-38  Link to Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.
  126. Journal Article Ruthotto F, Papendorf F, Wegener G, Unger G, Dlugosch B, Korangy F, Manns MP, Greten TF. Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancer.  Ann. Oncol.  2007;18;9  Link to Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancer.
  127. Journal Article Obermann S, Petrykowska S, Manns MP, Korangy F, Greten TF. Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.  Immunology  2007;122;1  Link to Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.
  128. Evaluation StudiesJournal Article Fytili P, Tiemann C, Wang C, Schulz S, Schaffer S, Manns MP, Wedemeyer H. Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay.  J. Clin. Virol.  2007;39;4  Link to Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay.
  129. Journal ArticleMulticenter Study Pradat P, Tillmann HL, Sauleda S, Braconier JH, Saracco G, Thursz M, Goldin R, Winkler R, Alberti A, Esteban JI, Hadziyannis S, Rizzetto M, Thomas H, Manns MP, Trepo C. Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications.  J. Viral Hepat.  2007;14;8  Link to Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications.
  130. Journal Article Tischendorf JJ, Meier PN, Schneider A, Manns MP, Krüger M. Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis.  Scand. J. Gastroenterol.  2007;42;8  Link to Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
  131. Clinical TrialJournal ArticleMulticenter Study Meier PN, Nietzschmann T, Akin I, Klose S, Manns MP. Improvement of objective GERD parameters after radiofrequency energy delivery: a European study.  Scand. J. Gastroenterol.  2007;42;8  Link to Improvement of objective GERD parameters after radiofrequency energy delivery: a European study.
  132. CommentJournal Article Herkel J, Manns MP, Lohse AW. Selenocysteine, soluble liver antigen/liver-pancreas, and autoimmune hepatitis.  Hepatology  2007;46;1  Link to Selenocysteine, soluble liver antigen/liver-pancreas, and autoimmune hepatitis.
  133. Case ReportsJournal Article Hadem J, Cornberg M, Länger F, Schedel I, Kirchhoff T, Niedermeyer J, Manns MP, Schöfl C. Making sense of muscle fatigue and liver lesions.  Z Gastroenterol  2007;45;7  Link to Making sense of muscle fatigue and liver lesions.
  134. Consensus Development ConferenceJournal ArticlePractice Guideline Cornberg M, Protzer U, Dollinger MM, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns MP. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011]  Z Gastroenterol  2007;45;6  Link to [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011]
  135. Journal Article Kirchhoff TD, Bleck JS, Dettmer A, Chavan A, Rosenthal H, Merkesdal S, Frericks B, Zender L, Malek NP, Greten TF, Kubicka S, Manns MP, Galanski M. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.  HBPD INT  2007;6;3  Link to Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
  136. Journal Article Ockenga J, Tietge UJ, Böker KH, Manns MP, Brabant G, Bahr MJ. Distinct roles of free leptin, bound leptin and soluble leptin receptor during the metabolic-inflammatory response in patients with liver cirrhosis.  Aliment. Pharmacol. Ther.  2007;25;11  Link to Distinct roles of free leptin, bound leptin and soluble leptin receptor during the metabolic-inflammatory response in patients with liver cirrhosis.
  137. CommentLetter Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infection--not a vanishing disease in Europe!  Hepatology  2007;45;5  Link to Hepatitis D virus infection--not a vanishing disease in Europe!
  138. Journal Article Richter A, Grabhorn E, Helmke K, Manns MP, Ganschow R, Burdelski M. Clinical relevance of autoantibodies after pediatric liver transplantation.  Clin Transplant  2007;21;3  Link to Clinical relevance of autoantibodies after pediatric liver transplantation.
  139. Journal ArticleReview McHutchison JG, Manns MP, Brown RS, Reddy KR, Shiffman ML, Wong JB. Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy.  Am. J. Gastroenterol.  2007;102;4  Link to Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy.
  140. Journal Article Rosenau J, Kreutz T, Kujawa M, Bahr MJ, Rifai K, Hooman N, Finger A, Michel G, Nashan B, Kuse ER, Klempnauer J, Tillmann HL, Manns MP. HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.  J. Hepatol.  2007;46;4  Link to HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
  141. Case ReportsJournal Article Tacke F, Amini-Bavil-Olyaee S, Heim A, Luedde T, Manns MP, Trautwein C. Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient.  J. Clin. Virol.  2007;38;4  Link to Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient.
  142. Journal Article Plentz RR, Park YN, Lechel A, Kim H, Nellessen F, Langkopf BH, Wilkens L, Destro A, Fiamengo B, Manns MP, Roncalli M, Rudolph KL. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis.  Hepatology  2007;45;4  Link to Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis.
  143. Journal Article Rifai K, Wedemeyer H, Rosenau J, Klempnauer J, Strassburg CP, Manns MP, Tillmann HL. Longer survival of liver transplant recipients with hepatitis virus coinfections.  Clin Transplant  2007;21;2  Link to Longer survival of liver transplant recipients with hepatitis virus coinfections.
  144. Clinical TrialJournal Article Rosenau J, Hooman N, Hadem J, Rifai K, Bahr MJ, Philipp G, Tillmann HL, Klempnauer J, Strassburg CP, Manns MP. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.  Liver Transpl.  2007;13;3  Link to Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.
  145. Case ReportsJournal Article Hadem J, Westerkamp V, Trautwein C, Winkler M, Manns MP, Hafer C. Hepatic gas gangrene following liver transplantation.  Liver Transpl.  2007;13;3  Link to Hepatic gas gangrene following liver transplantation.
  146. Journal Article Bachmann O, Heinzmann A, Mack A, Manns MP, Seidler U. Mechanisms of secretion-associated shrinkage and volume recovery in cultured rabbit parietal cells.  Am. J. Physiol. Gastrointest. Liver Physiol.  2007;292;3  Link to Mechanisms of secretion-associated shrinkage and volume recovery in cultured rabbit parietal cells.
  147. Journal Article Meyer MF, Wedemeyer H, Monazahian M, Dreesman J, Manns MP, Lehmann M. Prevalence of hepatitis C in a German prison for young men in relation to country of birth.  Epidemiol. Infect.  2007;135;2  Link to Prevalence of hepatitis C in a German prison for young men in relation to country of birth.
  148. Journal Article Korf M, Meyer A, Jarczak D, Beger C, Manns MP, Krüger M. Inhibition of HCV subgenomic replicons by siRNAs derived from plasmids with opposing U6 and H1 promoters.  J. Viral Hepat.  2007;14;2  Link to Inhibition of HCV subgenomic replicons by siRNAs derived from plasmids with opposing U6 and H1 promoters.
  149. Journal Article Gamrekelashvili J, Krüger C, von Wasielewski R, Hoffmann M, Huster KM, Busch DH, Manns MP, Korangy F, Greten TF. Necrotic tumor cell death in vivo impairs tumor-specific immune responses.  J. Immunol.  2007;178;3  Link to Necrotic tumor cell death in vivo impairs tumor-specific immune responses.
  150. Clinical TrialClinical Trial, Phase IIJournal ArticleRandomized Controlled Trial Wiegand J, Cornberg M, Aslan N, Schlaphoff V, Sarrazin C, Kubitschke A, Buggisch P, Ciner A, Jaeckel E, Manns MP, Wedemeyer H. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.  Antivir. Ther. (Lond.)  2007;12;3  Link to Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.
  151. Journal Article Meyer MF, Lehmann M, Cornberg M, Wiegand J, Manns MP, Klade C, Wedemeyer H. Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response.  Virol. J.  2007;4  Link to Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response.
  152. Case ReportsJournal Article Potthoff A, Deterding K, Trautwein C, Flemming P, Strassburg CP, Manns MP, Wedemeyer H, Bahr MJ. Steroid treatment for severe acute cryptogenic hepatitis.  Z Gastroenterol  2007;45;1  Link to Steroid treatment for severe acute cryptogenic hepatitis.
  153. Case ReportsJournal Article Trebst C, Wedemeyer H, Manns MP, Tillmann H, Windhagen A. Treatment of hepatitis C virus-associated inflammatory polyneuropathy with pegylated interferon-alpha and ribavirin.  Eur J Gastroenterol Hepatol  2007;19;1  Link to Treatment of hepatitis C virus-associated inflammatory polyneuropathy with pegylated interferon-alpha and ribavirin.
  154. Journal Article Kubitschke A, Bahr MJ, Aslan N, Bader C, Tillmann HL, Sarrazin C, Greten T, Wiegand J, Manns MP, Wedemeyer H. Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia.  Eur. J. Clin. Invest.  2007;37;1  Link to Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia.
  155. Journal ArticleRandomized Controlled Trial Hafer A, Krämer S, Duncker S, Krüger M, Manns MP, Bischoff SC. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.  BMC Gastroenterol  2007;7  Link to Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.
  156. Journal Article Tischendorf JJ, Hecker H, Krüger M, Manns MP, Meier PN. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study.  Am. J. Gastroenterol.  2007;102;1  Link to Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study.

    157. 2006

  157. Journal Article Deterding K, Tegtmeyer B, Cornberg M, Hadem J, Potthoff A, Böker KH, Tillmann HL, Manns MP, Wedemeyer H. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.  J. Hepatol.  2006;45;6  Link to Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
  158. Journal ArticleReview Greten TF, Manns MP, Korangy F. Immunotherapy of hepatocellular carcinoma.  J. Hepatol.  2006;45;6  Link to Immunotherapy of hepatocellular carcinoma.
  159. Journal Article Potthoff A, Tillmann HL, Bara C, Deterding K, Pethig K, Meyer S, Haverich A, Böker KH, Manns MP, Wedemeyer H. Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy.  J. Viral Hepat.  2006;13;11  Link to Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy.
  160. Journal Article Lankisch TO, Moebius U, Wehmeier M, Behrens G, Manns MP, Schmidt RE, Strassburg CP. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.  Hepatology  2006;44;5  Link to Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.
  161. Journal ArticleReview Strassburg CP, Manns MP. Approaches to liver biopsy techniques--revisited.  Semin. Liver Dis.  2006;26;4  Link to Approaches to liver biopsy techniques--revisited.
  162. Journal Article Kossatz U, Vervoorts J, Nickeleit I, Sundberg HA, Arthur JS, Manns MP, Malek NP. C-terminal phosphorylation controls the stability and function of p27kip1.  EMBO J.  2006;25;21  Link to C-terminal phosphorylation controls the stability and function of p27kip1.
  163. Editorial Manns MP, Sorrell MF. New diagnostic technology in liver disease.  Semin. Liver Dis.  2006;26;4  Link to New diagnostic technology in liver disease.
  164. Case ReportsLetter Schneider A, Attaran M, Meier PN, Strassburg C, Manns MP, Ott M, Barthold M, Arseniev L, Becker T, Panning B. Hepatocyte transplantation in an acute liver failure due to mushroom poisoning.  Transplantation  2006;82;8  Link to Hepatocyte transplantation in an acute liver failure due to mushroom poisoning.
  165. Journal Article Rosenau J, Hooman N, Rifai K, Solga T, Tillmann HL, Grzegowski E, Nashan B, Klempnauer J, Strassburg CP, Wedemeyer H, Manns MP. Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response.  Transpl. Int.  2006;19;10  Link to Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response.
  166. Journal ArticleReview Cornberg M, Deterding K, Manns MP. Present and future therapy for hepatitis C virus.  Expert Rev Anti Infect Ther  2006;4;5  Link to Present and future therapy for hepatitis C virus.
  167. Journal Article Tischendorf JJ, Meier PN, Strassburg CP, Klempnauer J, Hecker H, Manns MP, Krüger M. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.  Scand. J. Gastroenterol.  2006;41;10  Link to Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.
  168. CommentEditorialReview Strassburg CP, Manns MP. Autoimmune hepatitis in the elderly: what is the difference?  J. Hepatol.  2006;45;4  Link to Autoimmune hepatitis in the elderly: what is the difference?
  169. Journal Article Bachmann O, Reichelt D, Tuo B, Manns MP, Seidler U. Carbachol increases Na+-HCO3- cotransport activity in murine colonic crypts in a M3-, Ca2+/calmodulin-, and PKC-dependent manner.  Am. J. Physiol. Gastrointest. Liver Physiol.  2006;291;4  Link to Carbachol increases Na+-HCO3- cotransport activity in murine colonic crypts in a M3-, Ca2+/calmodulin-, and PKC-dependent manner.
  170. Comparative StudyJournal Article Tillmann HL, Kaiser T, Claes C, Schmidt RE, Manns MP, Stoll M. Differential influence of different hepatitis viruses on quality of life in HIV positive patients.  Eur. J. Med. Res.  2006;11;9  Link to Differential influence of different hepatitis viruses on quality of life in HIV positive patients.
  171. Journal Article Timmerbeul I, Garrett-Engele CM, Kossatz U, Chen X, Firpo E, Grünwald V, Kamino K, Wilkens L, Lehmann U, Buer J, Geffers R, Kubicka S, Manns MP, Porter PL, Roberts JM, Malek NP. Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer.  Proc. Natl. Acad. Sci. U.S.A.  2006;103;38  Link to Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer.
  172. Case ReportsEnglish AbstractJournal Article Ciesek S, Manns MP, Krüger M. [Retroperitoneal abscess in a man with severe necrotizing pancreatitis]  Dtsch. Med. Wochenschr.  2006;131;36  Link to [Retroperitoneal abscess in a man with severe necrotizing pancreatitis]
  173. Journal ArticleReview Manns MP, Wedemeyer H, Cornberg M. Treating viral hepatitis C: efficacy, side effects, and complications.  Gut  2006;55;9  Link to Treating viral hepatitis C: efficacy, side effects, and complications.
  174. Journal Article Aslan N, Yurdaydin C, Wiegand J, Greten T, Ciner A, Meyer MF, Heiken H, Kuhlmann B, Kaiser T, Bozkaya H, Tillmann HL, Bozdayi AM, Manns MP, Wedemeyer H. Cytotoxic CD4 T cells in viral hepatitis.  J. Viral Hepat.  2006;13;8  Link to Cytotoxic CD4 T cells in viral hepatitis.
  175. CommentComparative StudyLetter Wedemeyer H, Cornberg M, Wiegand J, Jäckel E, Manns MP. Treatment of acute hepatitis C-how to explain the differences?  Gastroenterology  2006;131;2  Link to Treatment of acute hepatitis C-how to explain the differences?
  176. Editorial Manns MP. [Preisdent's editorial, 2006]  Z Gastroenterol  2006;44;8  Link to [Preisdent's editorial, 2006]
  177. Journal Article Kirchner GI, Rifai K, Cantz T, Nashan B, Terkamp C, Becker T, Strassburg C, Barg-Hock H, Wagner S, Lück R, Klempnauer J, Manns MP. Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation.  Liver Transpl.  2006;12;8  Link to Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation.
  178. Controlled Clinical TrialJournal Article Bahr MJ, Ockenga J, Böker KH, Manns MP, Tietge UJ. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance.  Am. J. Physiol. Endocrinol. Metab.  2006;291;2  Link to Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance.
  179. Case ReportsLetter Ciesek S, Hadem J, Fischer J, Manns MP, Strassburg CP. A rare cause of nonalcoholic fatty liver disease.  Ann. Intern. Med.  2006;145;2  Link to A rare cause of nonalcoholic fatty liver disease.
  180. Comparative StudyIn VitroJournal Article Zschemisch NH, Liedtke C, Dierssen U, Nevzorova YA, Wüstefeld T, Borlak J, Manns MP, Trautwein C. Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo.  Hepatology  2006;44;1  Link to Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo.
  181. Journal Article Tischendorf JJ, Krüger M, Trautwein C, Duckstein N, Schneider A, Manns MP, Meier PN. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.  Endoscopy  2006;38;7  Link to Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
  182. Case ReportsEnglish AbstractJournal Article Rifai K, Flemming P, Manns MP, Trautwein C. [Severe drug hepatitis caused by Chelidonium]  Internist (Berl)  2006;47;7  Link to [Severe drug hepatitis caused by Chelidonium]
  183. Clinical TrialJournal Article Dettmer A, Kirchhoff TD, Gebel M, Zender L, Malek NP, Panning B, Chavan A, Rosenthal H, Kubicka S, Krusche S, Merkesdal S, Galanski M, Manns MP, Bleck JS. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.  World J. Gastroenterol.  2006;12;23  Link to Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
  184. Journal Article Volkmann X, Cornberg M, Wedemeyer H, Lehner F, Manns MP, Schulze-Osthoff K, Bantel H. Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection.  Hepatology  2006;43;6  Link to Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection.
  185. Journal Article Ormandy LA, Farber A, Cantz T, Petrykowska S, Wedemeyer H, Horning M, Lehner F, Manns MP, Korangy F, Greten TF. Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma.  World J. Gastroenterol.  2006;12;20  Link to Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma.
  186. Journal ArticleReview McHutchison JG, Manns MP, Longo DL. Definition and management of anemia in patients infected with hepatitis C virus.  Liver Int.  2006;26;4  Link to Definition and management of anemia in patients infected with hepatitis C virus.
  187. Journal ArticleRandomized Controlled Trial Rifai K, Ockenga J, Manns MP, Bischoff SC. Repeated administration of a vitamin preparation containing glycocholic acid in patients with hepatobiliary disease.  Aliment. Pharmacol. Ther.  2006;23;9  Link to Repeated administration of a vitamin preparation containing glycocholic acid in patients with hepatobiliary disease.
  188. Journal Article Ott M, Schneider A, Attaran M, Manns MP. [Transplantation of hepatocytes in liver failure]  Dtsch. Med. Wochenschr.  2006;131;16  Link to [Transplantation of hepatocytes in liver failure]
  189. Clinical TrialJournal ArticleMulticenter Study Tillmann HL, Hadem J, Leifeld L, Zachou K, Canbay A, Eisenbach C, Graziadei I, Encke J, Schmidt H, Vogel W, Schneider A, Spengler U, Gerken G, Dalekos GN, Wedemeyer H, Manns MP. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.  J. Viral Hepat.  2006;13;4  Link to Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
  190. Journal ArticleReview Rifai K, Manns MP. Review article: clinical experience with Prometheus.  Ther Apher Dial  2006;10;2  Link to Review article: clinical experience with Prometheus.
  191. Journal Article Sander LE, Lorentz A, Sellge G, Coëffier M, Neipp M, Veres T, Frieling T, Meier PN, Manns MP, Bischoff SC. Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract.  Gut  2006;55;4  Link to Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract.
  192. CommentLetter Fytili P, Ciesek S, Manns MP, Wedemeyer H, Neipp M, Helfritz F, Klempnauer J, Bara C, Haverich A. Anti-HBc seroconversion after transplantation of anti-HBc positive nonliver organs to anti-HBc negative recipients.  Transplantation  2006;81;5  Link to Anti-HBc seroconversion after transplantation of anti-HBc positive nonliver organs to anti-HBc negative recipients.
  193. Journal Article Tacke F, Fiedler K, von Depka M, Luedde T, Hecker H, Manns MP, Ganser A, Trautwein C. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.  Liver Int.  2006;26;2  Link to Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
  194. Comparative StudyJournal Article Rifai K, Kirchner GI, Bahr MJ, Cantz T, Rosenau J, Nashan B, Klempnauer JL, Manns MP, Strassburg CP. A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation.  Liver Transpl.  2006;12;3  Link to A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation.
  195. Journal Article Krüger M, Schneider AS, Manns MP, Meier PN. Endoscopic management of pancreatic pseudocysts or abscesses after an EUS-guided 1-step procedure for initial access.  Gastrointest. Endosc.  2006;63;3  Link to Endoscopic management of pancreatic pseudocysts or abscesses after an EUS-guided 1-step procedure for initial access.
  196. Clinical Trial, Phase IIJournal ArticleMulticenter StudyRandomized Controlled Trial Kirchhoff TD, Rudolph KL, Layer G, Chavan A, Greten TF, Rosenthal H, Kubicka S, Galanski M, Manns MP, Schild H, Gallkowski U. Chemoocclusion vs chemoperfusion for treatment of advanced hepatocellular carcinoma: a randomised trial.  Eur J Surg Oncol  2006;32;2  Link to Chemoocclusion vs chemoperfusion for treatment of advanced hepatocellular carcinoma: a randomised trial.
  197. Journal Article Rifai K, Ernst T, Kretschmer U, Haller H, Manns MP, Fliser D. Removal selectivity of Prometheus: a new extracorporeal liver support device.  World J. Gastroenterol.  2006;12;6  Link to Removal selectivity of Prometheus: a new extracorporeal liver support device.
  198. Clinical TrialJournal ArticleMulticenter Study Wiegand J, Buggisch P, Boecher W, Zeuzem S, Gelbmann CM, Berg T, Kauffmann W, Kallinowski B, Cornberg M, Jaeckel E, Wedemeyer H, Manns MP. Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study.  Hepatology  2006;43;2  Link to Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study.
  199. Journal ArticleRandomized Controlled Trial Cornberg M, Hadem J, Herrmann E, Schuppert F, Schmidt HH, Reiser M, Marschal O, Steffen M, Manns MP, Wedemeyer H. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.  J. Hepatol.  2006;44;2  Link to Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
  200. Comparative StudyIn VitroJournal Article Liedtke C, Gröger N, Manns MP, Trautwein C. Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells.  J. Hepatol.  2006;44;2  Link to Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells.
  201. Journal ArticleReview Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy.  Hepatology  2006;43;2 Suppl 1  Link to Autoimmune hepatitis, from mechanisms to therapy.
  202. Clinical TrialJournal Article Herrmann E, Zeuzem S, Sarrazin C, Hinrichsen H, Benhamou Y, Manns MP, Reiser M, Reesink H, Calleja JL, Forns X, Steinmann GG, Nehmiz G. Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061.  Antivir. Ther. (Lond.)  2006;11;3  Link to Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061.
  203. English AbstractJournal Article Meyer S, Manns MP, Wedemeyer H. [Three years of vertical networking in the German Network of Competence on Viral Hepatitis: what can we learn from the usage of different information tools?]  Z Gastroenterol  2006;44;1  Link to [Three years of vertical networking in the German Network of Competence on Viral Hepatitis: what can we learn from the usage of different information tools?]
  204. English AbstractJournal ArticleReview Greten TF, Blum HE, Manns MP, Geissler M. [Treatment of hepatocellular carcinoma]  Z Gastroenterol  2006;44;1  Link to [Treatment of hepatocellular carcinoma]
  205. Journal Article Garbe AI, Vermeer B, Gamrekelashvili J, von Wasielewski R, Greten FR, Westendorf AM, Buer J, Schmid RM, Manns MP, Korangy F, Greten TF. Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.  Cancer Res.  2006;66;1  Link to Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.

    206. 2005

  206. Journal Article Manns MP. [Perspectives in hepatology within the next 2-3 years: what becomes clinically relevant? Non-viral liver diseases]  Dtsch. Med. Wochenschr.  2005;130 Suppl 5  Link to [Perspectives in hepatology within the next 2-3 years: what becomes clinically relevant? Non-viral liver diseases]
  207. Case ReportsEnglish AbstractJournal Article Bachmann O, Baus S, Hoffmann MW, Manns MP, Gebel M. [Incarcerated Spieghel-Hernie mimicking an acute exacerbation of Crohn's disease]  Z Gastroenterol  2005;43;12  Link to [Incarcerated Spieghel-Hernie mimicking an acute exacerbation of Crohn's disease]
  208. Journal Article Boozari B, Gebel M, Bahr MJ, Manns MP, Strassburg CP, Bleck JS, Klempnauer J, Nashan B. Changes of duplex parameters and splenic size in liver transplant recipients during a long period of observation.  World J. Gastroenterol.  2005;11;43  Link to Changes of duplex parameters and splenic size in liver transplant recipients during a long period of observation.
  209. Journal Article Liedtke C, Zschemisch NH, Cohrs A, Roskams T, Borlak J, Manns MP, Trautwein C. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.  Gastroenterology  2005;129;5  Link to Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
  210. Journal Article Wuestefeld T, Klein C, Streetz KL, Beraza N, Schölmerich J, Burgart LJ, Zender L, Kubicka S, Baskin-Bey E, Gores GJ, Manns MP, Trautwein C. Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in mice.  Hepatology  2005;42;5  Link to Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in mice.
  211. Journal Article Mundt B, Wirth T, Zender L, Waltemathe M, Trautwein C, Manns MP, Kühnel F, Kubicka S. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake.  Gut  2005;54;11  Link to Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake.
  212. Journal Article Jarczak D, Korf M, Beger C, Manns MP, Krüger M. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.  FEBS J.  2005;272;22  Link to Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
  213. Case ReportsEnglish AbstractJournal Article Wedemeyer J, Gratz KF, Soudah B, Rosenthal H, Strassburg C, Terkamp C, Bahr MJ, Manns MP, Gebel MJ, Bleck JS. [Splenosis--important differential diagnosis in splenectomized patients presenting with abdominal masses of unknown origin]  Z Gastroenterol  2005;43;11  Link to [Splenosis--important differential diagnosis in splenectomized patients presenting with abdominal masses of unknown origin]
  214. Journal Article Djojosubroto MW, Chin AC, Go N, Schaetzlein S, Manns MP, Gryaznov S, Harley CB, Rudolph KL. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.  Hepatology  2005;42;5  Link to Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
  215. Clinical Trial, Phase IIJournal ArticleMulticenter Study Wiegand J, Schüler A, Kanzler S, Lohse A, Beuers U, Kreisel W, Spengler U, Koletzko S, Jansen PL, Hochhaus G, Möllmann HW, Pröls M, Manns MP. Budesonide in previously untreated autoimmune hepatitis.  Liver Int.  2005;25;5  Link to Budesonide in previously untreated autoimmune hepatitis.
  216. Case ReportsEnglish AbstractJournal Article Plentz RR, Lenzen H, Manns MP, Bleck JS. [Painless jaundice after holidays in Tanzania]  Internist (Berl)  2005;46;10  Link to [Painless jaundice after holidays in Tanzania]
  217. Journal Article Plentz RR, Tillmann HL, Kubicka S, Bleck JS, Gebel M, Manns MP, Rudolph KL. Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage.  J. Gastroenterol. Hepatol.  2005;20;9  Link to Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage.
  218. Journal Article Tacke F, Liedtke C, Bocklage S, Manns MP, Trautwein C. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.  Gut  2005;54;9  Link to CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.
  219. Journal ArticleReview Leuschner U, Manns MP, Eisebitt R. Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis.  Z Gastroenterol  2005;43;9  Link to Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis.
  220. Journal Article Plentz RR, Schlegelberger B, Flemming P, Gebel M, Kreipe H, Manns MP, Rudolph KL, Wilkens L. Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma.  Hepatology  2005;42;3  Link to Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma.
  221. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial Niro GA, Ciancio A, Tillman HL, Lagget M, Olivero A, Perri F, Fontana R, Little N, Campbell F, Smedile A, Manns MP, Andriulli A, Rizzetto M. Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study.  Aliment. Pharmacol. Ther.  2005;22;3  Link to Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study.
  222. English AbstractJournal ArticleReview Wedemeyer J, Malek NP, Manns MP, Bahr MJ. [Molecular therapy in gastroenterology and hepatology]  Internist (Berl)  2005;46;8  Link to [Molecular therapy in gastroenterology and hepatology]
  223. Comparative StudyIn VitroJournal Article Korf M, Jarczak D, Beger C, Manns MP, Krüger M. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors.  J. Hepatol.  2005;43;2  Link to Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors.
  224. Journal Article Gebhardt T, Lorentz A, Detmer F, Trautwein C, Bektas H, Manns MP, Bischoff SC. Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1.  Gut  2005;54;7  Link to Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1.
  225. Journal ArticleReview Cornberg M, Manns MP. New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C.  Ann Hepatol  2005;4;3  Link to New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C.
  226. English AbstractJournal ArticleReview Lankisch TO, Jaeckel E, Strassburg CP, Manns MP. [Autoimmune polyglandular syndromes]  Internist (Berl)  2005;46;7  Link to [Autoimmune polyglandular syndromes]
  227. Clinical TrialComparative StudyLetterRandomized Controlled Trial Plentz RR, Lankisch TO, Bastürk M, Müller CC, Kirchhoff T, Gebel M, Bleck JS, Kubicka S, Manns MP, Meier PN, Rudolph KL. Prospective analysis of German patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization with or without prophylactic antibiotic therapy.  J. Gastroenterol. Hepatol.  2005;20;7  Link to Prospective analysis of German patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization with or without prophylactic antibiotic therapy.
  228. Journal Article Seidel N, Volkmann X, Länger F, Flemming P, Manns MP, Schulze-Osthoff K, Bantel H. The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum.  Hepatology  2005;42;1  Link to The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum.
  229. Case ReportsJournal Article Lankisch TO, Strassburg CP, Debray D, Manns MP, Jacquemin E. Detection of autoimmune regulator gene mutations in children with type 2 autoimmune hepatitis and extrahepatic immune-mediated diseases.  J. Pediatr.  2005;146;6  Link to Detection of autoimmune regulator gene mutations in children with type 2 autoimmune hepatitis and extrahepatic immune-mediated diseases.
  230. Journal Article Lorentz A, Wilke M, Sellge G, Worthmann H, Klempnauer J, Manns MP, Bischoff SC. IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos.  J. Immunol.  2005;174;11  Link to IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos.
  231. Journal Article Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, Klempnauer J, Galanski M, Manns MP. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients.  Br. J. Cancer  2005;92;10  Link to Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients.
  232. Journal Article Tacke F, Wüstefeld T, Horn R, Luedde T, Srinivas Rao A, Manns MP, Trautwein C, Brabant G. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo.  J. Hepatol.  2005;42;5  Link to High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo.
  233. Comparative StudyJournal Article Rifai K, Bahr MJ, Cantz T, Klempnauer J, Manns MP, Strassburg CP. Severe hearing loss after liver transplantation.  Transplant. Proc.  2005;37;4  Link to Severe hearing loss after liver transplantation.
  234. Comparative StudyJournal Article Bahr MJ, Beckermann JG, Rifai K, Gehrmann L, Rosenau J, Klempnauer J, Strassburg CP, Manns MP. Retrospective analysis of the impact of immunosuppression on the course of recurrent hepatitis C after liver transplantation.  Transplant. Proc.  2005;37;4  Link to Retrospective analysis of the impact of immunosuppression on the course of recurrent hepatitis C after liver transplantation.
  235. Journal Article Bantel H, Strassburg CP, Manns MP. Autoimmune hepatitis.  Curr Gastroenterol Rep  2005;7;2  Link to Autoimmune hepatitis.
  236. Case ReportsLetter Greten TF, Manns MP, Reinisch I, Kaatsch P. Hepatocellular carcinoma occurring after successful treatment of childhood cancer with high dose chemotherapy and radiation.  Gut  2005;54;5  Link to Hepatocellular carcinoma occurring after successful treatment of childhood cancer with high dose chemotherapy and radiation.
  237. Journal Article Luedde T, Assmus U, Wüstefeld T, Meyer zu Vilsendorf A, Roskams T, Schmidt-Supprian M, Rajewsky K, Brenner DA, Manns MP, Pasparakis M, Trautwein C. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury.  J. Clin. Invest.  2005;115;4  Link to Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury.
  238. Journal Article Klein C, Wüstefeld T, Assmus U, Roskams T, Rose-John S, Müller M, Manns MP, Ernst M, Trautwein C. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.  J. Clin. Invest.  2005;115;4  Link to The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
  239. Case ReportsJournal Article Meier M, Woywodt A, Hoeper MM, Schneider A, Manns MP, Strassburg CP. Acute liver failure: a message found under the skin.  Postgrad Med J  2005;81;954  Link to Acute liver failure: a message found under the skin.
  240. Journal Article Gebhardt T, Gerhard R, Bedoui S, Erpenbeck VJ, Hoffmann MW, Manns MP, Bischoff SC. beta2-Adrenoceptor-mediated suppression of human intestinal mast cell functions is caused by disruption of filamentous actin dynamics.  Eur. J. Immunol.  2005;35;4  Link to beta2-Adrenoceptor-mediated suppression of human intestinal mast cell functions is caused by disruption of filamentous actin dynamics.
  241. Journal Article Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.  Cancer Res.  2005;65;6  Link to Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
  242. Journal Article Lechel A, Satyanarayana A, Ju Z, Plentz RR, Schaetzlein S, Rudolph C, Wilkens L, Wiemann SU, Saretzki G, Malek NP, Manns MP, Buer J, Rudolph KL. The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo.  EMBO Rep.  2005;6;3  Link to The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo.
  243. Clinical TrialJournal Article Kirchhoff T, Zender L, Merkesdal S, Frericks B, Malek N, Bleck J, Kubicka S, Baus S, Chavan A, Manns MP, Galanski M. Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver.  World J. Gastroenterol.  2005;11;8  Link to Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver.
  244. Journal Article Wiemann SU, Satyanarayana A, Buer J, Kamino K, Manns MP, Rudolph KL. Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage.  Oncogene  2005;24;9  Link to Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage.
  245. Journal ArticleReview Tillmann HL, Manns MP, Rudolph KL. Merging models of hepatitis C virus pathogenesis.  Semin. Liver Dis.  2005;25;1  Link to Merging models of hepatitis C virus pathogenesis.
  246. CommentLetter Luedde T, Tacke F, Manns MP, Trautwein C. p18(INK4c) expression in hepatocellular carcinoma.  Hepatology  2005;41;2  Link to p18(INK4c) expression in hepatocellular carcinoma.
  247. Journal Article Zender L, Hütker S, Mundt B, Waltemathe M, Klein C, Trautwein C, Malek NP, Manns MP, Kühnel F, Kubicka S. NFkappaB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis.  Hepatology  2005;41;2  Link to NFkappaB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis.
  248. Journal Article Jaeckel E, von Boehmer H, Manns MP. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes.  Diabetes  2005;54;2  Link to Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes.
  249. CommentLetter Siebert U, Wasem J, Rossol S, Sroczynski G, Aidelsburger P, Ravens-Sieberer U, Kurth BM, Manns MP, McHutchison JG, Wong JB. Antiviral treatment initiation costs in chronic hepatitis C.  Gut  2005;54;1  Link to Antiviral treatment initiation costs in chronic hepatitis C.
  250. In VitroJournal Article Ciesek S, Ringe BP, Strassburg CP, Klempnauer J, Manns MP, Wedemeyer H, Becker T. Effects of cyclosporine on human dendritic cell subsets.  Transplant. Proc.  2005;37;1  Link to Effects of cyclosporine on human dendritic cell subsets.
  251. Journal Article Potthoff A, Sarhaddar J, Wiegand J, Lichtinghagen R, Sarrazin C, Ciner A, Hadem J, Trautwein C, Manns MP, Wedemeyer H. Spontaneous resolution of chronic hepatitis C virus infection after antiviral treatment and relapse.  Hepatol. Res.  2005;31;1  Link to Spontaneous resolution of chronic hepatitis C virus infection after antiviral treatment and relapse.
  252. Comparative StudyEvaluation StudiesJournal ArticleValidation Studies Tillmann HL, Wiegand J, Glomb I, Jelineck A, Picchio G, Wedemeyer H, Manns MP. Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay.  Z Gastroenterol  2005;43;1  Link to Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay.
  253. Journal ArticleReview Czaja AJ, Bianchi FB, Carpenter HA, Krawitt EL, Lohse AW, Manns MP, McFarlane IG, Mieli-Vergani G, Toda G, Vergani D, Vierling J, Zeniya M. Treatment challenges and investigational opportunities in autoimmune hepatitis.  Hepatology  2005;41;1  Link to Treatment challenges and investigational opportunities in autoimmune hepatitis.
  254. Journal Article Alexandrova K, Griesel C, Barthold M, Heuft HG, Ott M, Winkler M, Schrem H, Manns MP, Bredehorn T, Net M, Vidal MM, Kafert-Kasting S, Arseniev L. Large-scale isolation of human hepatocytes for therapeutic application.  Cell Transplant  2005;14;10  Link to Large-scale isolation of human hepatocytes for therapeutic application.

    255. 2004

  255. CommentEditorial Manns MP, Wedemeyer H. Treatment of hepatitis C in HIV-infected patients: significant progress but not the final step.  JAMA  2004;292;23  Link to Treatment of hepatitis C in HIV-infected patients: significant progress but not the final step.
  256. CommentJournal Article Wedemeyer H, Manns MP. Can epoetin alfa maintain ribavirin doses in patients with hepatitis C virus on combination therapy?  Nature clinical practice. Gastroenterology & hepatology  2004;1;1  Link to Can epoetin alfa maintain ribavirin doses in patients with hepatitis C virus on combination therapy?
  257. English AbstractJournal Article Strassburg CP, Becker T, Klempnauer J, Manns MP. [Liver transplantation: deciding between need and donor allocation]  Internist (Berl)  2004;45;11  Link to [Liver transplantation: deciding between need and donor allocation]
  258. Journal Article Bantel H, Lügering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, Manns MP, Schulze-Osthoff K. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury.  Hepatology  2004;40;5  Link to Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury.
  259. Comparative StudyEnglish AbstractJournal Article Wedemeyer J, Kirchhoff T, Manns MP, Gebel MJ, Bleck JS. [Transcutaneous perianal ultrasound (PAUS) for the imaging of fistulas and abscesses in Crohn's disease]  Z Gastroenterol  2004;42;11  Link to [Transcutaneous perianal ultrasound (PAUS) for the imaging of fistulas and abscesses in Crohn's disease]
  260. Journal Article Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schüler A, Ennen JC, Ahl B, Manns MP, Böker KW. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy.  J. Hepatol.  2004;41;5  Link to Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy.
  261. Journal Article Attaran M, Schneider A, Grote C, Zwiens C, Flemming P, Gratz KF, Jochheim A, Bahr MJ, Manns MP, Ott M. Regional and transient ischemia/reperfusion injury in the liver improves therapeutic efficacy of allogeneic intraportal hepatocyte transplantation in low-density lipoprotein receptor deficient Watanabe rabbits.  J. Hepatol.  2004;41;5  Link to Regional and transient ischemia/reperfusion injury in the liver improves therapeutic efficacy of allogeneic intraportal hepatocyte transplantation in low-density lipoprotein receptor deficient Watanabe rabbits.
  262. Comparative StudyJournal Article Satyanarayana A, Geffers R, Manns MP, Buer J, Rudolph KL. Gene expression profile at the G1/S transition of liver regeneration after partial hepatectomy in mice.  Cell Cycle  2004;3;11  Link to Gene expression profile at the G1/S transition of liver regeneration after partial hepatectomy in mice.
  263. English AbstractJournal ArticleReview Jaeckel E, Becker T, Manns MP. [Organ transplantation in endocrinology. Islet cells and pancreas]  Internist (Berl)  2004;45;11  Link to [Organ transplantation in endocrinology. Islet cells and pancreas]
  264. GuidelineJournal ArticlePractice Guideline Vergani D, Alvarez F, Bianchi FB, Cançado EL, Mackay IR, Manns MP, Nishioka M, Penner E. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group.  J. Hepatol.  2004;41;4  Link to Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group.
  265. CommentLetter Tacke F, Luedde T, Manns MP, Trautwein C. Regulation of plasma erythropoietin in chronic liver disease.  World J. Gastroenterol.  2004;10;19  Link to Regulation of plasma erythropoietin in chronic liver disease.
  266. Journal Article Tischendorf JJ, Beger C, Korf M, Manns MP, Krüger M. Polypyrimidine tract-binding protein (PTB) inhibits Hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation, but does not affect HCV replication.  Arch. Virol.  2004;149;10  Link to Polypyrimidine tract-binding protein (PTB) inhibits Hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation, but does not affect HCV replication.
  267. Journal Article Wedemeyer J, Kirchhoff T, Sellge G, Bachmann O, Lotz J, Galanski M, Manns MP, Gebel MJ, Bleck JS. Transcutaneous perianal sonography: a sensitive method for the detection of perianal inflammatory lesions in Crohn's disease.  World J. Gastroenterol.  2004;10;19  Link to Transcutaneous perianal sonography: a sensitive method for the detection of perianal inflammatory lesions in Crohn's disease.
  268. Journal ArticleReview Satyanarayana A, Manns MP, Rudolph KL. Telomeres, telomerase and cancer: an endless search to target the ends.  Cell Cycle  2004;3;9  Link to Telomeres, telomerase and cancer: an endless search to target the ends.
  269. Journal ArticleReview Lechel A, Manns MP, Rudolph KL. Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.  J. Hepatol.  2004;41;3  Link to Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.
  270. English AbstractJournal Article Tischendorf JJ, Crede S, Herrmann P, Bach N, Bömeke C, Manns MP, Schaefer O, Trautwein C. [Encoding of diagnosis by medical documentation assistant or ward physician. Influence on the mapping of Diagnostic Related Group (DRG) performance]  Dtsch. Med. Wochenschr.  2004;129;33  Link to [Encoding of diagnosis by medical documentation assistant or ward physician. Influence on the mapping of Diagnostic Related Group (DRG) performance]
  271. English AbstractJournal Article Caselitz M, Masche N, Flemming P, Stern C, Manns MP, Wagner S, Kubicka S. [Prognosis of hepatocellular carcinoma according to new staging classifications]  Dtsch. Med. Wochenschr.  2004;129;33  Link to [Prognosis of hepatocellular carcinoma according to new staging classifications]
  272. Journal ArticleReview Fleig WE, Krummenerl P, Lesske J, Dienes HP, Zeuzem S, Schmiegel WH, Häussinger D, Burdelski M, Manns MP. [Diagnosis, progression and therapy of hepatitis C virus infection as well as viral infection in children and adolescents--results of an evidenced based consensus conference of the German Society for Alimentary Metabolic Disorders and and in cooperation with the Hepatitis Competence Network]  Z Gastroenterol  2004;42;8  Link to [Diagnosis, progression and therapy of hepatitis C virus infection as well as viral infection in children and adolescents--results of an evidenced based consensus conference of the German Society for Alimentary Metabolic Disorders and and in cooperation with the Hepatitis Competence Network]
  273. Journal ArticleReview Manns MP, Caselmann WH, Wiedmann KH, Wedemeyer H. [Standard treatment of chronic hepatitis B]  Z Gastroenterol  2004;42;8  Link to [Standard treatment of chronic hepatitis B]
  274. Consensus Development ConferenceJournal ArticleReview Manns MP, Wedemeyer H, Meyer S, Roggendorf M, Niederau C, Blum HE, Jilg W, Fleig WE. [Diagnosis, progression and therapy of hepatitis-B-virus infection--results of an evidenced based consensus conference of the German Society for Alimentary Metabolic Disorders and and in cooperation with the Hepatitis Competence Network]  Z Gastroenterol  2004;42;8  Link to [Diagnosis, progression and therapy of hepatitis-B-virus infection--results of an evidenced based consensus conference of the German Society for Alimentary Metabolic Disorders and and in cooperation with the Hepatitis Competence Network]
  275. Journal Article Tillmann HL, Manns MP, Claes C, Heiken H, Schmidt RE, Stoll M. GB virus C infection and quality of life in HIV-positive patients.  AIDS Care  2004;16;6  Link to GB virus C infection and quality of life in HIV-positive patients.
  276. Journal Article Luedde T, Duderstadt M, Streetz KL, Tacke F, Kubicka S, Manns MP, Trautwein C. C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver.  Hepatology  2004;40;2  Link to C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver.
  277. Journal Article Tacke F, Gehrke C, Luedde T, Heim A, Manns MP, Trautwein C. Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.  J. Virol.  2004;78;16  Link to Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.
  278. Journal Article Tietge UJ, Selberg O, Kreter A, Bahr MJ, Pirlich M, Burchert W, Müller MJ, Manns MP, Böker KH. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.  Liver Transpl.  2004;10;8  Link to Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
  279. Journal ArticleReview Satyanarayana A, Manns MP, Rudolph KL. Telomeres and telomerase: a dual role in hepatocarcinogenesis.  Hepatology  2004;40;2  Link to Telomeres and telomerase: a dual role in hepatocarcinogenesis.
  280. English AbstractJournal ArticleReview Rifai K, Manns MP, Bahr MJ. [Liver transplantation for metabolic liver disease in adulthood]  Z Gastroenterol  2004;42;8  Link to [Liver transplantation for metabolic liver disease in adulthood]
  281. Journal Article Pradat P, Maynard M, Buti M, Berthillon P, Picchio G, Tillmann HL, Wiegand J, Voirin N, Manns MP, Esteban JI, Martinot M, Marcellin P, Trepo C. The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment.  J. Med. Virol.  2004;73;3  Link to The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment.
  282. Journal Article Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H. Long-term follow-up after successful interferon therapy of acute hepatitis C.  Hepatology  2004;40;1  Link to Long-term follow-up after successful interferon therapy of acute hepatitis C.
  283. Journal Article Lehmann M, Meyer MF, Monazahian M, Tillmann HL, Manns MP, Wedemeyer H. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.  J. Med. Virol.  2004;73;3  Link to High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
  284. Journal Article Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP, Greten TF. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.  Clin. Cancer Res.  2004;10;13  Link to Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
  285. Journal Article Plentz RR, Caselitz M, Bleck JS, Gebel M, Flemming P, Kubicka S, Manns MP, Rudolph KL. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma.  Hepatology  2004;40;1  Link to Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma.
  286. Clinical TrialControlled Clinical TrialJournal Article Tietge UJ, Böker KH, Manns MP, Bahr MJ. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.  Am. J. Physiol. Endocrinol. Metab.  2004;287;1  Link to Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
  287. Journal Article Bachmann O, Riederer B, Rossmann H, Groos S, Schultheis PJ, Shull GE, Gregor M, Manns MP, Seidler U. The Na+/H+ exchanger isoform 2 is the predominant NHE isoform in murine colonic crypts and its lack causes NHE3 upregulation.  Am. J. Physiol. Gastrointest. Liver Physiol.  2004;287;1  Link to The Na+/H+ exchanger isoform 2 is the predominant NHE isoform in murine colonic crypts and its lack causes NHE3 upregulation.
  288. English AbstractJournal ArticleReview Hadem J, Wedemeyer H, Manns MP. [Hepatitis as a travel disease]  Internist (Berl)  2004;45;6  Link to [Hepatitis as a travel disease]
  289. Case ReportsJournal Article Luedde T, Tacke F, Chavan A, Länger F, Klempnauer J, Manns MP. Yersinia infection mimicking recurrence of gastrointestinal stromal tumor.  Scand. J. Gastroenterol.  2004;39;6  Link to Yersinia infection mimicking recurrence of gastrointestinal stromal tumor.
  290. Case ReportsCommentLetter Krüger M, Behrens J, Länger F, Manns MP, Meier PN. Intramucosal adenocarcinoma of the appendix.  Endoscopy  2004;36;6  Link to Intramucosal adenocarcinoma of the appendix.
  291. Journal Article Battegay M, Manns MP. [Travel in a smaller world]  Internist (Berl)  2004;45;6  Link to [Travel in a smaller world]
  292. Journal Article Schaetzlein S, Lucas-Hahn A, Lemme E, Kues WA, Dorsch M, Manns MP, Niemann H, Rudolph KL. Telomere length is reset during early mammalian embryogenesis.  Proc. Natl. Acad. Sci. U.S.A.  2004;101;21  Link to Telomere length is reset during early mammalian embryogenesis.
  293. CommentEditorialReview Wedemeyer H, Jäckel E, Wiegand J, Cornberg M, Manns MP. Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C.  Hepatology  2004;39;5  Link to Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C.
  294. Case ReportsEnglish AbstractJournal Article Plentz RR, Müller CC, Laenger F, Manns MP, Meier PN. [Lichen planus esophagitis without skin, genital or oral mucosa involvement]  Z Gastroenterol  2004;42;5  Link to [Lichen planus esophagitis without skin, genital or oral mucosa involvement]
  295. CommentLetter Jaeckel E, Wedemeyer H, Wiegand J, Manns MP. Acute hepatitis C virus infection: to treat or not to treat?  Gastroenterology  2004;126;4  Link to Acute hepatitis C virus infection: to treat or not to treat?
  296. English AbstractJournal Article Wedemeyer H, Meyer S, Manns MP. [Hepatitis (Hep-Net) competence network]  Internist (Berl)  2004;45;4  Link to [Hepatitis (Hep-Net) competence network]
  297. Journal Article Ehmer U, Vogel A, Schütte JK, Krone B, Manns MP, Strassburg CP. Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.  Hepatology  2004;39;4  Link to Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.
  298. Journal Article Bischoff SC, Schwengberg S, Lorentz A, Manns MP, Bektas H, Sann H, Levi-Schaffer F, Shanahan F, Schemann M. Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells.  Neurogastroenterol. Motil.  2004;16;2  Link to Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells.
  299. CommentEditorialReview Bahr MJ, Manns MP. Changing faces-natural course and treatment of hepatitis C after liver transplantation.  J. Hepatol.  2004;40;4  Link to Changing faces-natural course and treatment of hepatitis C after liver transplantation.
  300. Journal Article Tietge UJ, Cichon G, Büttner C, Genschel J, Heeren J, Gielow P, Grewe N, Dogar M, Beisiegel U, Manns MP, Lochs H, Burchert W, Schmidt HH. A sensitive noninvasive method for monitoring successful liver-directed gene transfer of the low-density lipoprotein receptor in Watanabe hyperlipidemic rabbits in vivo.  Gene Ther.  2004;11;7  Link to A sensitive noninvasive method for monitoring successful liver-directed gene transfer of the low-density lipoprotein receptor in Watanabe hyperlipidemic rabbits in vivo.
  301. Journal Article Tacke F, Schöffski P, Luedde T, Meier PN, Ganser A, Manns MP, Trautwein C. Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease.  Scand. J. Gastroenterol.  2004;39;3  Link to Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease.
  302. Journal Article Manns MP. Adherence to combination therapy: influence on sustained virologic response and economic impact.  Gastroenterol. Clin. North Am.  2004;33;1 Suppl  Link to Adherence to combination therapy: influence on sustained virologic response and economic impact.
  303. Journal Article Vogel A, Heinrich E, Bahr MJ, Rifai K, Flemming P, Melter M, Klempnauer J, Nashan B, Manns MP, Strassburg CP. Long-term outcome of liver transplantation for autoimmune hepatitis.  Clin Transplant  2004;18;1  Link to Long-term outcome of liver transplantation for autoimmune hepatitis.
  304. Case ReportsJournal Article Wedemeyer J, Gebel MJ, Lotz J, Schlue J, Manns MP, Bleck JS. Malignant lymphoma accompanied by renal cell carcinoma - a not so rare coincidence?  Ultraschall Med  2004;25;1  Link to Malignant lymphoma accompanied by renal cell carcinoma - a not so rare coincidence?
  305. Journal Article Söderbergh A, Myhre AG, Ekwall O, Gebre-Medhin G, Hedstrand H, Landgren E, Miettinen A, Eskelin P, Halonen M, Tuomi T, Gustafsson J, Husebye ES, Perheentupa J, Gylling M, Manns MP, Rorsman F, Kämpe O, Nilsson T. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I.  J. Clin. Endocrinol. Metab.  2004;89;2  Link to Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I.
  306. Journal Article Sellge G, Lorentz A, Gebhardt T, Levi-Schaffer F, Bektas H, Manns MP, Schuppan D, Bischoff SC. Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor.  J. Immunol.  2004;172;1  Link to Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor.
  307. Case ReportsComparative StudyJournal Article Wiegand J, Tischendorf JJ, Nashan B, Klempnauer J, Flemming P, Niemann P, Rohde P, Manns MP, Trautwein C, Tillmann HL. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.  Z Gastroenterol  2004;42;1  Link to Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.
  308. English AbstractJournal ArticleReview Strassburg CP, Manns MP. [Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy]  Internist (Berl)  2004;45;1  Link to [Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy]
  309. Journal Article Cantz T, Sharma AD, Jochheim-Richter A, Arseniev L, Klein C, Manns MP, Ott M. Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration.  Cell Transplant  2004;13;6  Link to Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration.
  310. Journal Article Ledig S, Wagner S, Manns MP, Beil W, Athmann C. Role of the receptor-mediated apoptosis in Helicobacter pylori in gastric epithelial cells.  Digestion  2004;70;3  Link to Role of the receptor-mediated apoptosis in Helicobacter pylori in gastric epithelial cells.
  311. Journal Article Mössner J, Manns MP. [Diagnosis and therapy of biliary tract diseases. An assessment of the current status]  Internist (Berl)  2004;45;1  Link to [Diagnosis and therapy of biliary tract diseases. An assessment of the current status]

    312. 2003

  312. Journal Article Flemming P, Tillmann HL, Barg-Hock H, Kleeberger W, Manns MP, Klempnauer J, Kreipe HH. Donor origin of de novo hepatocellular carcinoma in hepatic allografts.  Transplantation  2003;76;11  Link to Donor origin of de novo hepatocellular carcinoma in hepatic allografts.
  313. Comparative StudyEnglish AbstractJournal ArticleReview Rifai K, Bahr MJ, Schneider A, Ott M, Manns MP. [New devices in liver replacement therapy]  Med. Klin. (Munich)  2003;98;12  Link to [New devices in liver replacement therapy]
  314. Case ReportsJournal Article Bahr MJ, Schubert J, Bleck JS, Tietge UJ, Boozari B, Schmidt RE, Klempnauer J, Strassburg CP, Manns MP. Recurrence of Budd-Chiari syndrome after liver transplantation in paroxysmal nocturnal hemoglobinuria.  Transpl. Int.  2003;16;12  Link to Recurrence of Budd-Chiari syndrome after liver transplantation in paroxysmal nocturnal hemoglobinuria.
  315. Journal Article Bahr MJ, el Menuawy M, Boeker KH, Musholt PB, Manns MP, Lichtinghagen R. Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C.  Liver Int.  2003;23;6  Link to Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C.
  316. Comparative StudyEnglish AbstractJournal ArticleReview Rifai K, Ott M, Bahr MM, Schneider A, Manns MP. [Liver replacement therapy. Reliable indications in acute liver failure]  Internist (Berl)  2003;44;12  Link to [Liver replacement therapy. Reliable indications in acute liver failure]
  317. Clinical TrialJournal Article Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D. Prometheus--a new extracorporeal system for the treatment of liver failure.  J. Hepatol.  2003;39;6  Link to Prometheus--a new extracorporeal system for the treatment of liver failure.
  318. Journal Article Umemura T, Tanaka E, Ostapowicz G, Brown KE, Heringlake S, Tassopoulos NC, Wang RY, Yeo AE, Shih JW, Orii K, Young NS, Hatzakis A, Manns MP, Lee WM, Kiyosawa K, Alter HJ. Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis.  J. Infect. Dis.  2003;188;10  Link to Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis.
  319. Clinical TrialComparative StudyJournal ArticleMulticenter StudyRandomized Controlled Trial Wong JB, Davis GL, McHutchison JG, Manns MP, Albrecht JK. Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C.  Am. J. Gastroenterol.  2003;98;11  Link to Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C.
  320. Journal Article Dalekos GN, Obermayer-Straub P, Bartels M, Maeda T, Kayser A, Braun S, Loges S, Schmidt E, Gershwin ME, Manns MP. Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection.  J. Hepatol.  2003;39;5  Link to Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection.
  321. Journal Article Flemming P, Tillmann HL, Barg-Hock H, Kleeberger W, Manns MP, Klempnauer J, Kreipe HH. Donor origin of de novo hepatocellular carcinoma in hepatic allografts.  Transplantation  2003;76;5  Link to Donor origin of de novo hepatocellular carcinoma in hepatic allografts.
  322. Journal Article Davis GL, Wong JB, McHutchison JG, Manns MP, Harvey J, Albrecht J. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.  Hepatology  2003;38;3  Link to Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.
  323. News Manns MP, Meyer S, Wedemeyer H. The German network of excellence for viral hepatitis (Hep-Net).  Hepatology  2003;38;3  Link to The German network of excellence for viral hepatitis (Hep-Net).
  324. Journal Article Tillmann HL, Klempnauer J, Manns MP. Risks and benefits of nucleosides before and after liver transplantation.  Transplant. Proc.  2003;35;6  Link to Risks and benefits of nucleosides before and after liver transplantation.
  325. Journal Article Plentz RR, Wiemann SU, Flemming P, Meier PN, Kubicka S, Kreipe H, Manns MP, Rudolph KL. Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer.  Gut  2003;52;9  Link to Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer.
  326. Comparative StudyJournal Article Lichtinghagen R, Bahr MJ, Wehmeier M, Michels D, Haberkorn CI, Arndt B, Flemming P, Manns MP, Boeker KH. Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis.  Clinical science (London, England : 1979)  2003;105;3  Link to Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis.
  327. Journal Article Streetz KL, Wüstefeld T, Klein C, Kallen KJ, Tronche F, Betz UA, Schütz G, Manns MP, Müller W, Trautwein C. Lack of gp130 expression in hepatocytes promotes liver injury.  Gastroenterology  2003;125;2  Link to Lack of gp130 expression in hepatocytes promotes liver injury.
  328. Journal Article Klein C, Wüstefeld T, Heinrich PC, Streetz KL, Manns MP, Trautwein C. ME3738 protects from concanavalin A-induced liver failure via an IL-6-dependent mechanism.  Eur. J. Immunol.  2003;33;8  Link to ME3738 protects from concanavalin A-induced liver failure via an IL-6-dependent mechanism.
  329. Journal Article Satyanarayana A, Wiemann SU, Buer J, Lauber J, Dittmar KE, Wüstefeld T, Blasco MA, Manns MP, Rudolph KL. Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells.  EMBO J.  2003;22;15  Link to Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells.
  330. Case ReportsJournal Article Wedemeyer H, Kuipers JG, Streetz K, Mengel M, Schedel I, Kezmic N, Meier P, Zeidler H, Manns MP, Wagner S. A rare manifestation of Behçet's syndrome: immunological correlates and successful treatment of an esophageal ulcer.  Dig. Dis. Sci.  2003;48;7  Link to A rare manifestation of Behçet's syndrome: immunological correlates and successful treatment of an esophageal ulcer.
  331. Journal Article Klein C, Bock CT, Wedemeyer H, Wüstefeld T, Locarnini S, Dienes HP, Kubicka S, Manns MP, Trautwein C. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.  Gastroenterology  2003;125;1  Link to Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.
  332. Journal Article Streetz KL, Tacke F, Leifeld L, Wüstefeld T, Graw A, Klein C, Kamino K, Spengler U, Kreipe H, Kubicka S, Müller W, Manns MP, Trautwein C. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.  Hepatology  2003;38;1  Link to Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.
  333. Journal Article Zender L, Hutker S, Liedtke C, Tillmann HL, Zender S, Mundt B, Waltemathe M, Gosling T, Flemming P, Malek NP, Trautwein C, Manns MP, Kuhnel F, Kubicka S. Caspase 8 small interfering RNA prevents acute liver failure in mice.  Proc. Natl. Acad. Sci. U.S.A.  2003;100;13  Link to Caspase 8 small interfering RNA prevents acute liver failure in mice.
  334. Journal ArticleReview Tillmann HL, Manns MP. [Indications for liver transplantation]  Dtsch. Med. Wochenschr.  2003;128 Suppl 2  Link to [Indications for liver transplantation]
  335. Journal ArticleReview Strassburg CP, Manns MP. [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis]  Dtsch. Med. Wochenschr.  2003;128 Suppl 2  Link to [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis]
  336. Comparative StudyEnglish AbstractJournal Article Cornberg M, Hüppe D, Wiegand J, Felten G, Wedemeyer H, Manns MP. [Treatment of chronic hepatitis C with PEG-interferon alpha-2b and ribavirin: 24 weeks of therapy are sufficient for HCV genotype 2 and 3]  Z Gastroenterol  2003;41;6  Link to [Treatment of chronic hepatitis C with PEG-interferon alpha-2b and ribavirin: 24 weeks of therapy are sufficient for HCV genotype 2 and 3]
  337. Journal Article Bock CT, Buerke B, Tillmann HL, Tacke F, Kliem V, Manns MP, Trautwein C. Relevance of hepatitis B core gene deletions in patients after kidney transplantation.  Gastroenterology  2003;124;7  Link to Relevance of hepatitis B core gene deletions in patients after kidney transplantation.
  338. Case ReportsLetter Tischendorf JJ, Grosse V, Flik J, Verhagen W, Manns MP, Trautwein C. Fulminant course of herpes simplex virus reactivation in an apparently immunocompetent woman.  Int. J. Infect. Dis.  2003;7;2  Link to Fulminant course of herpes simplex virus reactivation in an apparently immunocompetent woman.
  339. Journal Article Ockenga J, Vogel A, Teich N, Keim V, Manns MP, Strassburg CP. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer.  Gastroenterology  2003;124;7  Link to UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer.
  340. Comparative StudyJournal Article Caselitz M, Masche N, Bleck JS, Gebel M, Atay Z, Stern C, Manns MP, Kubicka S. Increasing sensitivity of morphological diagnosis in hepatocellular carcinoma (HCC) by combination of cytological and fine-needle histological examination after ultrasound guided fine needle biopsy.  Z Gastroenterol  2003;41;6  Link to Increasing sensitivity of morphological diagnosis in hepatocellular carcinoma (HCC) by combination of cytological and fine-needle histological examination after ultrasound guided fine needle biopsy.
  341. Journal Article Muerhoff AS, Tillmann HL, Manns MP, Dawson GJ, Desai SM. GB virus C genotype determination in GB virus-C/HIV co-infected individuals.  J. Med. Virol.  2003;70;1  Link to GB virus C genotype determination in GB virus-C/HIV co-infected individuals.
  342. Editorial Manns MP, Wagner S. [Gastroenterologic emergencies. Updates in diagnosis and therapy]  Internist (Berl)  2003;44;5  Link to [Gastroenterologic emergencies. Updates in diagnosis and therapy]
  343. Clinical TrialControlled Clinical TrialJournal Article Caselitz M, Bahr MJ, Bleck JS, Chavan A, Manns MP, Wagner S, Gebel M. Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT).  Hepatology  2003;37;5  Link to Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT).
  344. Journal Article Tacke F, Brabant G, Kruck E, Horn R, Schöffski P, Hecker H, Manns MP, Trautwein C. Ghrelin in chronic liver disease.  J. Hepatol.  2003;38;4  Link to Ghrelin in chronic liver disease.
  345. Journal ArticleReview Strassburg CP, Manns MP. Transition of care between paediatric and adult gastroenterology. Autoimmune hepatitis.  Best Pract Res Clin Gastroenterol  2003;17;2  Link to Transition of care between paediatric and adult gastroenterology. Autoimmune hepatitis.
  346. Journal Article Tietge UJ, Bahr MJ, Manns MP, Böker KH. Altered alanine plasma levels despite normalized hepatic alanine extraction in the long-term course after liver transplantation.  Transplantation  2003;75;6  Link to Altered alanine plasma levels despite normalized hepatic alanine extraction in the long-term course after liver transplantation.
  347. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial Siebert U, Sroczynski G, Rossol S, Wasem J, Ravens-Sieberer U, Kurth BM, Manns MP, McHutchison JG, Wong JB. Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.  Gut  2003;52;3  Link to Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.
  348. Journal Article Leifeld L, Dumoulin FL, Purr I, Janberg K, Trautwein C, Wolff M, Manns MP, Sauerbruch T, Spengler U. Early up-regulation of chemokine expression in fulminant hepatic failure.  J. Pathol.  2003;199;3  Link to Early up-regulation of chemokine expression in fulminant hepatic failure.
  349. Case ReportsLetter Rollnik JD, Meier PN, Manns MP, Göke M. Antral injections of botulinum a toxin for the treatment of obesity.  Ann. Intern. Med.  2003;138;4  Link to Antral injections of botulinum a toxin for the treatment of obesity.
  350. Journal Article Schneider A, Attaran M, Gratz KF, Bleck JS, Winkler M, Manns MP, Ott M. Intraportal infusion of 99mtechnetium-macro-aggregrated albumin particles and hepatocytes in rabbits: assessment of shunting and portal hemodynamic changes.  Transplantation  2003;75;3  Link to Intraportal infusion of 99mtechnetium-macro-aggregrated albumin particles and hepatocytes in rabbits: assessment of shunting and portal hemodynamic changes.
  351. Case ReportsJournal Article Tillmann HL, Bock CT, Bleck JS, Rosenau J, Böker KH, Barg-Hock H, Becker T, Trautwein C, Klempnauer J, Flemming P, Manns MP. Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency.  Liver Transpl.  2003;9;2  Link to Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency.
  352. Case ReportsJournal Article Weissenborn K, Tietge UJ, Bokemeyer M, Mohammadi B, Bode U, Manns MP, Caselitz M. Liver transplantation improves hepatic myelopathy: evidence by three cases.  Gastroenterology  2003;124;2  Link to Liver transplantation improves hepatic myelopathy: evidence by three cases.
  353. Journal Article Scheffer SR, Nave H, Korangy F, Schlote K, Pabst R, Jaffee EM, Manns MP, Greten TF. Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo.  Int. J. Cancer  2003;103;2  Link to Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo.
  354. Journal ArticleReview Tillmann HL, Wedemeyer H, Manns MP. Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation.  J. Hepatol.  2003;39 Suppl 1  Link to Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation.
  355. Case ReportsJournal Article Streetz KL, Buhr T, Wedemeyer H, Bleck J, Schedel I, Manns MP, Göke MN. Acute CMV-colitis in a patient with a history of ulcerative colitis.  Scand. J. Gastroenterol.  2003;38;1  Link to Acute CMV-colitis in a patient with a history of ulcerative colitis.
  356. Comparative StudyJournal Article Vogel A, Strassburg CP, Manns MP. 77 C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link.  Genes Immun.  2003;4;1  Link to 77 C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link.
  357. Journal Article Bahr MJ, Manns MP. Recurrent hepatitis C in transplanted patients: more questions than answers.  Dig Liver Dis  2003;35;1  Link to Recurrent hepatitis C in transplanted patients: more questions than answers.
  358. Journal Article Tietge UJ, Bahr MJ, Manns MP, Böker KH. Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation.  Transpl. Int.  2003;16;1  Link to Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation.
  359. Editorial Manns MP, Schneider A, Meier PN. Minilaparoscopy for early diagnosis of cirrhosis: is the endoscopist's eye better than the histopathologist's?  Endoscopy  2003;35;1  Link to Minilaparoscopy for early diagnosis of cirrhosis: is the endoscopist's eye better than the histopathologist's?
  360. Journal Article Cantz T, Zuckerman DM, Burda MR, Dandri M, Göricke B, Thalhammer S, Heckl WM, Manns MP, Petersen J, Ott M. Quantitative gene expression analysis reveals transition of fetal liver progenitor cells to mature hepatocytes after transplantation in uPA/RAG-2 mice.  Am. J. Pathol.  2003;162;1  Link to Quantitative gene expression analysis reveals transition of fetal liver progenitor cells to mature hepatocytes after transplantation in uPA/RAG-2 mice.

    361. 2002

  361. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Greten TF, Korangy F, Neumann G, Wedemeyer H, Schlote K, Heller A, Scheffer S, Pardoll DM, Garbe AI, Schneck JP, Manns MP. Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes.  J. Immunol. Methods  2002;271;1-2  Link to Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes.
  362. Journal Article Cornberg M, Hinrichsen H, Teuber G, Berg T, Naumann U, Falkenberg C, Zeuzem S, Manns MP. Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C.  J. Hepatol.  2002;37;6  Link to Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C.
  363. Journal ArticleReview Vogel A, Wedemeyer H, Manns MP, Strassburg CP. Autoimmune hepatitis and overlap syndromes.  J. Gastroenterol. Hepatol.  2002;17 Suppl 3  Link to Autoimmune hepatitis and overlap syndromes.
  364. Journal ArticleReview Wedemeyer H, Wiegand J, Cornberg M, Manns MP. Polyethylene glycol-interferon: current status in hepatitis C virus therapy.  J. Gastroenterol. Hepatol.  2002;17 Suppl 3  Link to Polyethylene glycol-interferon: current status in hepatitis C virus therapy.
  365. Journal Article Sugimura T, Obermayer-Straub P, Kayser A, Braun S, Loges S, Alex B, Lüttig B, Johnson EF, Manns MP, Strassburg CP. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.  Autoimmunity  2002;35;8  Link to A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
  366. Journal Article Strassburg CP, Manns MP. [Partial liver transplantation and living donation from the viewpoint of internal medicine]  Internist (Berl)  2002;43;12  Link to [Partial liver transplantation and living donation from the viewpoint of internal medicine]
  367. Journal Article Manns MP, Strassburg CP. [Autoimmune hepatitis]  Z Gastroenterol  2002;40 Suppl 2  Link to [Autoimmune hepatitis]
  368. CommentLetter Bahr MJ, Rosenau J, Manns MP. Discussion on the association between hepatitis C infection and survival after orthotopic liver transplantation.  Gastroenterology  2002;123;6  Link to Discussion on the association between hepatitis C infection and survival after orthotopic liver transplantation.
  369. Comparative StudyEnglish AbstractJournal Article Teubner A, Tillmann HL, Schuppan D, Gericke G, Manns MP, Stölzel U. [Prevalence of circulating autoantibodies in healthy individuals]  Med. Klin. (Munich)  2002;97;11  Link to [Prevalence of circulating autoantibodies in healthy individuals]
  370. Letter Wedemeyer H, Manns MP. [Acute hepatitis C--therapy with interferon alpha-2b]]  Internist (Berl)  2002;43;11  Link to [Acute hepatitis C--therapy with interferon alpha-2b]]
  371. Journal ArticleReview Strassburg CP, Manns MP. Autoantibodies and autoantigens in autoimmune hepatitis.  Semin. Liver Dis.  2002;22;4  Link to Autoantibodies and autoantigens in autoimmune hepatitis.
  372. Comparative StudyJournal Article Arkenau HT, Stichtenoth DO, Frölich JC, Manns MP, Böker KH. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.  Z Gastroenterol  2002;40;11  Link to Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
  373. Case ReportsJournal ArticleReview Kirchner GI, Wagner S, Flemming P, Bleck JS, Gebel M, Schedel I, Schüler A, Galanski M, Manns MP. COACH syndrome associated with multifocal liver tumors.  Am. J. Gastroenterol.  2002;97;10  Link to COACH syndrome associated with multifocal liver tumors.
  374. Case ReportsJournal Article Grosse V, Bange FC, Tischendorf J, Schmidt RE, Manns MP. A mass in the eye.  Lancet  2002;360;9337  Link to A mass in the eye.
  375. Comparative StudyEvaluation StudiesJournal Article Raymondos K, Panning B, Bachem I, Manns MP, Piepenbrock S, Meier PN. Evaluation of endoscopic retrograde cholangiopancreatography under conscious sedation and general anesthesia.  Endoscopy  2002;34;9  Link to Evaluation of endoscopic retrograde cholangiopancreatography under conscious sedation and general anesthesia.
  376. Journal Article Liedtke C, Plümpe J, Kubicka S, Bradham CA, Manns MP, Brenner DA, Trautwein C. Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells.  Hepatology  2002;36;2  Link to Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells.
  377. Clinical TrialJournal Article Yurdaydin C, Bozkaya H, Gürel S, Tillmann HL, Aslan N, Okçu-Heper A, Erden E, Yalçin K, Iliman N, Uzunalimoglu O, Manns MP, Bozdayi AM. Famciclovir treatment of chronic delta hepatitis.  J. Hepatol.  2002;37;2  Link to Famciclovir treatment of chronic delta hepatitis.
  378. Journal ArticleReview Vogel A, Manns MP, Strassburg CP. Autoimmunity and viruses.  Clin Liver Dis  2002;6;3  Link to Autoimmunity and viruses.
  379. Journal Article Bahr MJ, Rosenau J, Tietge UJ, Caselitz M, Hofmann MW, Klempnauer J, Böker KH, Strassburg CP, Manns MP. Immunosuppression and the prognosis of patients suffering from myeloproliferative disorders after liver transplantation.  Transplant. Proc.  2002;34;5  Link to Immunosuppression and the prognosis of patients suffering from myeloproliferative disorders after liver transplantation.
  380. Journal Article Gebhardt T, Sellge G, Lorentz A, Raab R, Manns MP, Bischoff SC. Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release.  Eur. J. Immunol.  2002;32;8  Link to Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release.
  381. Journal Article Vogel A, Ockenga J, Ehmer U, Barut A, Kramer FJ, Tukey RH, Manns MP, Strassburg CP. Polymorphisms of the carcinogen detoxifying UDP-glucuronosyltransferase UGT1A7 in proximal digestive tract cancer.  Z Gastroenterol  2002;40;7  Link to Polymorphisms of the carcinogen detoxifying UDP-glucuronosyltransferase UGT1A7 in proximal digestive tract cancer.
  382. Case ReportsJournal Article Caselitz M, Manns MP, Meier PN. Endoscopic management of duodenal diverticulitis causing common bile duct obstruction and cholangitis.  Endoscopy  2002;34;7  Link to Endoscopic management of duodenal diverticulitis causing common bile duct obstruction and cholangitis.
  383. Journal Article Tacke F, Trautwein C, Zhao S, Andreeff M, Manns MP, Ganser A, Schöffski P. Quantification of hepatic thrombopoietin mRNA transcripts in patients with chronic liver diseases shows maintained gene expression in different etiologies of liver cirrhosis.  Liver  2002;22;3  Link to Quantification of hepatic thrombopoietin mRNA transcripts in patients with chronic liver diseases shows maintained gene expression in different etiologies of liver cirrhosis.
  384. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Strassburg CP, Vogel A, Kneip S, Tukey RH, Manns MP. Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer.  Gut  2002;50;6  Link to Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer.
  385. English AbstractJournal Article Heiken H, Stoll M, Tillmann HL, Manns MP, Schmidt RE. [Helper cells, viral load, genetic factors, co-infections. Prognostic factors in HIV-1 infection]  MMW Fortschr Med  2002;144 Suppl 1  Link to [Helper cells, viral load, genetic factors, co-infections. Prognostic factors in HIV-1 infection]
  386. Comparative StudyJournal Article Schöffski P, Tacke F, Trautwein C, Martin MU, Caselitz M, Hecker H, Manns MP, Ganser A. Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease.  Liver  2002;22;2  Link to Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease.
  387. Case ReportsJournal Article Bergwitz C, Brabant G, Trautwein C, Manns MP. A patient with autoimmune hepatitis type I, Addison's disease, atrophic thyroiditis, atrophic gastritis, exocrine pancreatic insufficiency, and heterozygous alpha1-antitrypsin deficiency.  Am. J. Gastroenterol.  2002;97;4  Link to A patient with autoimmune hepatitis type I, Addison's disease, atrophic thyroiditis, atrophic gastritis, exocrine pancreatic insufficiency, and heterozygous alpha1-antitrypsin deficiency.
  388. Letter Tillmann HL, Stoll M, Manns MP, Schmidt RE, Heiken H. Chemokine receptor polymorphisms and GB virus C status in HIV-positive patients.  AIDS  2002;16;5  Link to Chemokine receptor polymorphisms and GB virus C status in HIV-positive patients.
  389. Letter Tillmann HL, Trautwein C, Bock CT, Glomb I, Krüger M, Böker KH, Klempnauer J, Flemming P, Manns MP. Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitis.  Am. J. Gastroenterol.  2002;97;3  Link to Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitis.
  390. Journal Article Rosenau J, Bahr MJ, von Wasielewski R, Mengel M, Schmidt HH, Nashan B, Lang H, Klempnauer J, Manns MP, Boeker KH. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.  Transplantation  2002;73;3  Link to Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.
  391. Journal ArticleReview Cornberg M, Wedemeyer H, Manns MP. Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.  Curr Gastroenterol Rep  2002;4;1  Link to Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.
  392. Journal Article Lorentz A, Schuppan D, Gebert A, Manns MP, Bischoff SC. Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins.  Blood  2002;99;3  Link to Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins.
  393. Journal Article Bock CT, Tillmann HL, Torresi J, Klempnauer J, Locarnini S, Manns MP, Trautwein C. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation.  Gastroenterology  2002;122;2  Link to Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation.
  394. Journal Article Strassburg CP, Strassburg A, Kneip S, Barut A, Tukey RH, Rodeck B, Manns MP. Developmental aspects of human hepatic drug glucuronidation in young children and adults.  Gut  2002;50;2  Link to Developmental aspects of human hepatic drug glucuronidation in young children and adults.
  395. Journal Article Tietge UJ, Bahr MJ, Manns MP, Böker KH. Plasma amino acids in cirrhosis and after liver transplantation: influence of liver function, hepatic hemodynamics and circulating hormones.  Clin Transplant  2002;16;1  Link to Plasma amino acids in cirrhosis and after liver transplantation: influence of liver function, hepatic hemodynamics and circulating hormones.
  396. Case ReportsJournal Article Strassburg CP, Schnarr S, Körbel JN, Flemming P, Bischoff SC, Manns MP. [Clubbed fingers and dysphagia in a 38-year-old patient]  Internist (Berl)  2002;43;1  Link to [Clubbed fingers and dysphagia in a 38-year-old patient]
  397. Journal Article Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis.  Hepatology  2002;35;1  Link to Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis.
  398. Journal ArticleReview Manns MP. Current state of interferon therapy in the treatment of chronic hepatitis B.  Semin. Liver Dis.  2002;22 Suppl 1  Link to Current state of interferon therapy in the treatment of chronic hepatitis B.
  399. Journal Article Dalekos GN, Makri E, Loges S, Obermayer-Straub P, Zachou K, Tsikrikas T, Schmidt E, Papadamou G, Manns MP. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.  Eur J Gastroenterol Hepatol  2002;14;1  Link to Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.

    400. 2001

  400. Journal Article Tietge UJ, Bahr MJ, Manns MP, Böker KH. Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation.  Liver Transpl.  2001;7;12  Link to Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation.
  401. Case ReportsEnglish AbstractJournal Article Göke MN, Leppert A, Flemming P, Soudah B, Bange FC, Bleck JS, Widjaja A, Högemann B, Mellmann J, Ockenga J, Schedel I, Gebel M, Manns MP. [Intestinal tuberculosis: Easier overlooked than diagnosed]  Z Gastroenterol  2001;39;12  Link to [Intestinal tuberculosis: Easier overlooked than diagnosed]
  402. Clinical TrialJournal ArticleMulticenter Study Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP. Treatment of acute hepatitis C with interferon alfa-2b.  N. Engl. J. Med.  2001;345;20  Link to Treatment of acute hepatitis C with interferon alfa-2b.
  403. Journal Article Rosenau J, Tillmann HL, Bahr MJ, Trautwein C, Boeker KH, Nashan B, Klempnauer J, Manns MP. Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation.  Transplant. Proc.  2001;33;7-8  Link to Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation.
  404. Journal ArticleReview Tillmann HL, Manns MP. GB virus-C infection in patients infected with the human immunodeficiency virus.  Antiviral Res.  2001;52;2  Link to GB virus-C infection in patients infected with the human immunodeficiency virus.
  405. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Vogel A, Kneip S, Barut A, Ehmer U, Tukey RH, Manns MP, Strassburg CP. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.  Gastroenterology  2001;121;5  Link to Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.
  406. Case ReportsJournal Article Benten D, Widjaja A, von Depka M, Flemming P, Trautwein C, Böker K, Vogel A, Rosenau J, Manns MP. Autoimmune hepatitis associated with coagulation disorders and immunethyreopathy.  Z Gastroenterol  2001;39;10  Link to Autoimmune hepatitis associated with coagulation disorders and immunethyreopathy.
  407. Journal ArticleReview Cantz T, Ott M, Kubicka S, Manns MP. [Gene and immunotherapy of liver diseases]  Internist (Berl)  2001;42;10  Link to [Gene and immunotherapy of liver diseases]
  408. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled TrialResearch Support, U.S. Gov't, P.H.S. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.  Lancet  2001;358;9286  Link to Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.
  409. Journal Article Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, Goergen B, Detmer J, McMorrow M, Stoll M, Schmidt RE, Manns MP. Infection with GB virus C and reduced mortality among HIV-infected patients.  N. Engl. J. Med.  2001;345;10  Link to Infection with GB virus C and reduced mortality among HIV-infected patients.
  410. Journal Article Obermayer-Straub P, Perheentupa J, Braun S, Kayser A, Barut A, Loges S, Harms A, Dalekos G, Strassburg CP, Manns MP. Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.  Gastroenterology  2001;121;3  Link to Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
  411. Case ReportsJournal Article Braune C, Widjaja A, Bartels M, Bleck JS, Flemming P, Manns MP, Klempnauer J, Gebel M. Surgical removal of a distinct subcutaneous metastasis of multilocular hepatocellular carcinoma 2 months after initial percutaneous ethanol injection therapy.  Z Gastroenterol  2001;39;9  Link to Surgical removal of a distinct subcutaneous metastasis of multilocular hepatocellular carcinoma 2 months after initial percutaneous ethanol injection therapy.
  412. Journal Article Lüdde T, Kubicka S, Plümpe J, Liedtke C, Manns MP, Trautwein C. Ras adenoviruses modulate cyclin E protein expression and DNA synthesis after partial hepatectomy.  Oncogene  2001;20;38  Link to Ras adenoviruses modulate cyclin E protein expression and DNA synthesis after partial hepatectomy.
  413. English AbstractJournal ArticleReview Bahr MJ, Manns MP. [Function of the immune system in liver cirrhosis]  Z Gastroenterol  2001;39;8  Link to [Function of the immune system in liver cirrhosis]
  414. Case ReportsEnglish AbstractJournal Article Kirchner GI, Krug N, Bleck JS, Fliser D, Manns MP, Wagner S. [Fulminant course of leptospirosis complicated by multiple organ failure]  Z Gastroenterol  2001;39;8  Link to [Fulminant course of leptospirosis complicated by multiple organ failure]
  415. Journal ArticleReview Bischoff SC, Manns MP. [Food allergies]  Internist (Berl)  2001;42;8  Link to [Food allergies]
  416. Journal ArticleReview Meier PN, Manns MP. Medical and endoscopic treatment in primary sclerosing cholangitis.  Best Pract Res Clin Gastroenterol  2001;15;4  Link to Medical and endoscopic treatment in primary sclerosing cholangitis.
  417. CommentLetter Ockenga J, Stuhrmann M, Manns MP. Evaluation of the role of CFTR in alcohol related pancreatic disease.  Gut  2001;49;2  Link to Evaluation of the role of CFTR in alcohol related pancreatic disease.
  418. Journal Article Streetz K, Fregien B, Plümpe J, Körber K, Kubicka S, Sass G, Bischoff SC, Manns MP, Tiegs G, Trautwein C. Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in Con A-induced liver failure.  J. Immunol.  2001;167;1  Link to Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in Con A-induced liver failure.
  419. English AbstractJournal ArticleReview Caselitz M, Chavan A, Manns MP, Wagner S. [Hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) and its manifestation in the liver]  Z Gastroenterol  2001;39;7  Link to [Hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) and its manifestation in the liver]
  420. Journal ArticleReview Wedemeyer H, Cornberg M, Manns MP. [PEG-interferons: significance for the treatment of viral hepatitis B and C]  Dtsch. Med. Wochenschr.  2001;126 Suppl 1  Link to [PEG-interferons: significance for the treatment of viral hepatitis B and C]
  421. Clinical TrialClinical Trial, Phase IIJournal Article van Nunen AB, Baumann M, Manns MP, Reichen J, Spengler U, Marschner JP, de Man RA. Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patients.  Liver  2001;21;3  Link to Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patients.
  422. Journal Article Rosenau J, Bahr MJ, Tillmann HL, Trautwein C, Klempnauer J, Manns MP, Böker KHW None. Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.  J. Hepatol.  2001;34;6  Link to Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.
  423. Journal ArticleReview Trautwein C, Manns MP. [Antiviral therapy of chronic viral hepatitis]  Internist (Berl)  2001;42;6  Link to [Antiviral therapy of chronic viral hepatitis]
  424. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Ros JE, Schuetz JD, Geuken M, Streetz K, Moshage H, Kuipers F, Manns MP, Jansen PL, Trautwein C, Müller M. Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signaling.  Hepatology  2001;33;6  Link to Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signaling.
  425. In VitroJournal Article Strassburg CP, Barut A, Obermayer-Straub P, Li Q, Nguyen N, Tukey RH, Manns MP. Identification of cyclosporine A and tacrolimus glucuronidation in human liver and the gastrointestinal tract by a differentially expressed UDP-glucuronosyltransferase: UGT2B7.  J. Hepatol.  2001;34;6  Link to Identification of cyclosporine A and tacrolimus glucuronidation in human liver and the gastrointestinal tract by a differentially expressed UDP-glucuronosyltransferase: UGT2B7.
  426. Journal ArticleReview Bleck JS, Gebel M, Boozari B, Manns MP. [Advances in the ultrasonic diagnosis of liver diseases]  Dtsch. Med. Wochenschr.  2001;126 Suppl 1  Link to [Advances in the ultrasonic diagnosis of liver diseases]
  427. CommentLetter Tillmann HL, Rosenau J, Trautwein C, Boeker KH, Manns MP. Successful orthotopic liver transplantation.  Gastroenterology  2001;120;6  Link to Successful orthotopic liver transplantation.
  428. Journal Article Tillmann HL, Chen DF, Trautwein C, Kliem V, Grundey A, Berning-Haag A, Böker K, Kubicka S, Pastucha L, Stangel W, Manns MP. Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease.  Gut  2001;48;5  Link to Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease.
  429. Journal Article Vogel A, Liermann H, Harms A, Strassburg CP, Manns MP, Obermayer-Straub P. Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1.  Hepatology  2001;33;5  Link to Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1.
  430. Journal ArticleReview Manns MP, Strassburg CP. Autoimmune hepatitis: clinical challenges.  Gastroenterology  2001;120;6  Link to Autoimmune hepatitis: clinical challenges.
  431. Case ReportsJournal Article Schmidt HH, Genschel J, Baier P, Schmidt M, Ockenga J, Tietge UJ, Pröpsting M, Büttner C, Manns MP, Lochs H, Brabant G. Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene.  J. Clin. Endocrinol. Metab.  2001;86;5  Link to Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene.
  432. Journal ArticleReview Obermayer-Straub P, Manns MP. Hepatitis C and D, retroviruses and autoimmune manifestations.  J. Autoimmun.  2001;16;3  Link to Hepatitis C and D, retroviruses and autoimmune manifestations.
  433. Journal ArticleReview Cornberg M, Wedemeyer H, Manns MP. Hepatitis C: therapeutic perspectives.  Forum (Genova)  2001;11;2  Link to Hepatitis C: therapeutic perspectives.
  434. Clinical TrialComparative StudyControlled Clinical TrialJournal Article Widjaja A, Wedemeyer H, Tillmann HL, Horn R, Ockenga J, Jaeckel E, von zur Mühlen A, Manns MP, Brabant G. Hepatitis C and the leptin system: bound leptin levels are elevated in patients with hepatitis C and decrease during antiviral therapy.  Scand. J. Gastroenterol.  2001;36;4  Link to Hepatitis C and the leptin system: bound leptin levels are elevated in patients with hepatitis C and decrease during antiviral therapy.
  435. CommentLetter Wedemeyer H, Pethig K, Manns MP, Böker KH. Hepatitis B infection in heart transplant patients.  Gastroenterology  2001;120;5  Link to Hepatitis B infection in heart transplant patients.
  436. Journal ArticleReview Manns MP, Cornberg M, Wedemeyer H. Current and future treatment of hepatitis C.  Indian J Gastroenterol  2001;20 Suppl 1  Link to Current and future treatment of hepatitis C.
  437. Journal Article Wesche B, Jaeckel E, Trautwein C, Wedemeyer H, Falorni A, Frank H, von zur Mühlen A, Manns MP, Brabant G. Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C.  Gut  2001;48;3  Link to Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C.
  438. Journal Article Volkmann M, Martin L, Bäurle A, Heid H, Strassburg CP, Trautwein C, Fiehn W, Manns MP. Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis.  Hepatology  2001;33;3  Link to Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis.
  439. Journal ArticleMulticenter Study Manns MP, Neuhaus P, Atkinson GF, Griffin KE, Barnass S, Vollmar J, Yeang Y, Young CL. Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study.  Transplant infectious disease : an official journal of the Transplantation Society  2001;3;1  Link to Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study.
  440. Case ReportsJournal Article Csepregi A, Nemesánszky E, Luettig B, Obermayer-Straub P, Manns MP. LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity.  Am. J. Gastroenterol.  2001;96;3  Link to LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity.
  441. Clinical TrialJournal ArticleRandomized Controlled Trial Schlitt HJ, Barkmann A, Böker KH, Schmidt HH, Emmanouilidis N, Rosenau J, Bahr MJ, Tusch G, Manns MP, Nashan B, Klempnauer J. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.  Lancet  2001;357;9256  Link to Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.
  442. Journal Article Lichtinghagen R, Michels D, Haberkorn CI, Arndt B, Bahr M, Flemming P, Manns MP, Boeker KH. Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.  J. Hepatol.  2001;34;2  Link to Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
  443. Journal Article Kirchner GI, Jacobsen W, Deters M, Christians U, Nashan B, Winkler M, Vidal C, Kaever V, Sewing K, Manns MP. Fast quantification method for sirolimus and its major metabolites.  Transplant. Proc.  2001;33;1-2  Link to Fast quantification method for sirolimus and its major metabolites.
  444. Comparative StudyJournal Article Dömland M, Gebel M, Teichgräber UK, Manns MP. The role of Doppler velocity histograms of hepatic veins in early detection of cirrhotic changes of the liver parenchyma.  Ultraschall Med  2001;22;1  Link to The role of Doppler velocity histograms of hepatic veins in early detection of cirrhotic changes of the liver parenchyma.
  445. Journal ArticleReview Plesch FN, Kubicka S, Manns MP. Prevention of hepatocellular carcinoma in chronic liver disease: molecular markers and clinical implications.  Dig Dis  2001;19;4  Link to Prevention of hepatocellular carcinoma in chronic liver disease: molecular markers and clinical implications.

    446. 2000

  446. Journal Article Ockenga J, Bischoff SC, Tillmann HL, Rifai K, Widjaja A, Böker KH, Manns MP, Brabant G. Elevated bound leptin correlates with energy expenditure in cirrhotics.  Gastroenterology  2000;119;6  Link to Elevated bound leptin correlates with energy expenditure in cirrhotics.
  447. Interview Manns MP. [Cell culture for the sick liver. Will cirrhosis soon be curable?. Interview by Petra Eiden.]  MMW Fortschr Med  2000;142;45  Link to [Cell culture for the sick liver. Will cirrhosis soon be curable?. Interview by Petra Eiden.]
  448. Letter Stölzel U, Schuppan D, Tillmann HL, Manns MP, Tannapfel A, Doss MO, Zimmer T, Koszka C, Köstler E. Autoantibodies in porphyria cutanea tarda: a controlled study.  J. Hepatol.  2000;33;5  Link to Autoantibodies in porphyria cutanea tarda: a controlled study.
  449. English AbstractJournal Article Piso P, Werner U, Bektas H, Kubicka S, Manns MP, Klempnauer J. [Peritoneal carcinosis in appendiceal carcinoma--at what price can the prognosis be improved?]  Dtsch. Med. Wochenschr.  2000;125;43  Link to [Peritoneal carcinosis in appendiceal carcinoma--at what price can the prognosis be improved?]
  450. Journal Article Tietze MK, Wuestefeld T, Paul Y, Zender L, Trautwein C, Manns MP, Kubicka S. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.  Cancer Gene Ther.  2000;7;10  Link to IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
  451. Journal Article Mix H, Widjaja A, Jandl O, Cornberg M, Kaul A, Göke M, Beil W, Kuske M, Brabant G, Manns MP, Wagner S. Expression of leptin and leptin receptor isoforms in the human stomach.  Gut  2000;47;4  Link to Expression of leptin and leptin receptor isoforms in the human stomach.
  452. Journal ArticleReview Bischoff SC, Ockenga J, Manns MP. [Artificial nutrition in intensive internal medicine. Chances and problems]  Internist (Berl)  2000;41;10  Link to [Artificial nutrition in intensive internal medicine. Chances and problems]
  453. CommentEditorial Manns MP, Bahr MJ. Recurrent autoimmune hepatitis after liver transplantation-when non-self becomes self.  Hepatology  2000;32;4 Pt 1  Link to Recurrent autoimmune hepatitis after liver transplantation-when non-self becomes self.
  454. Journal Article Mierke CT, Ballmaier M, Werner U, Manns MP, Welte K, Bischoff SC. Human endothelial cells regulate survival and proliferation of human mast cells.  J. Exp. Med.  2000;192;6  Link to Human endothelial cells regulate survival and proliferation of human mast cells.
  455. Comparative StudyJournal Article Trautwein C, Possienke M, Schlitt HJ, Böker KH, Horn R, Raab R, Manns MP, Brabant G. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation.  Am. J. Gastroenterol.  2000;95;9  Link to Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation.
  456. Journal Article Wüstefeld T, Rakemann T, Kubicka S, Manns MP, Trautwein C. Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice.  Hepatology  2000;32;3  Link to Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice.
  457. CommentEditorialReview Strassburg CP, Manns MP. Jaundice, genes and promoters.  J. Hepatol.  2000;33;3  Link to Jaundice, genes and promoters.
  458. Journal ArticleReview Kubicka S, Manns MP. [Gallbladder and bile duct carcinoma]  Internist (Berl)  2000;41;9  Link to [Gallbladder and bile duct carcinoma]
  459. Editorial Classen M, Manns MP. [Gastrointestinal oncology]  Internist (Berl)  2000;41;9  Link to [Gastrointestinal oncology]
  460. Journal ArticleReview Streetz KL, Luedde T, Manns MP, Trautwein C. Interleukin 6 and liver regeneration.  Gut  2000;47;2  Link to Interleukin 6 and liver regeneration.
  461. Journal ArticleReview Strassburg CP, Manns MP. Autoimmune tests in primary biliary cirrhosis.  Baillieres Best Pract Res Clin Gastroenterol  2000;14;4  Link to Autoimmune tests in primary biliary cirrhosis.
  462. Journal Article Dömland M, Gebel M, Caselitz M, Bleck J, Manns MP. Comparison of portal venous flow in cirrhotic patients with and without paraumbilical vein patency using duplex-sonography.  Ultraschall Med  2000;21;4  Link to Comparison of portal venous flow in cirrhotic patients with and without paraumbilical vein patency using duplex-sonography.
  463. Case ReportsJournal Article Rademaker J, Widjaja A, Manns MP, Galanski M. Angiosarcoma of the liver presenting with esophageal bleeding and arterio-portal shunts.  J. Hepatol.  2000;33;2  Link to Angiosarcoma of the liver presenting with esophageal bleeding and arterio-portal shunts.
  464. CommentEditorialReview Manns MP. Antibodies to soluble liver antigen: specific marker of autoimmune hepatitis.  J. Hepatol.  2000;33;2  Link to Antibodies to soluble liver antigen: specific marker of autoimmune hepatitis.
  465. Journal Article Ockenga J, Stuhrmann M, Ballmann M, Teich N, Keim V, Dörk T, Manns MP. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis.  Am. J. Gastroenterol.  2000;95;8  Link to Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis.
  466. Journal Article Schüler A, Manns MP. Patients with chronic hepatitis C--who should not be treated?  Can. J. Gastroenterol.  2000;14 Suppl B  Link to Patients with chronic hepatitis C--who should not be treated?
  467. Journal ArticleReview Touzet S, Kraemer L, Colin C, Pradat P, Lanoir D, Bailly F, Coppola RC, Sauleda S, Thursz MR, Tillmann H, Alberti A, Braconier JH, Esteban JI, Hadziyannis SJ, Manns MP, Saracco G, Thomas HC, Trépo C. Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research.  Eur J Gastroenterol Hepatol  2000;12;6  Link to Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research.
  468. Journal Article Barkmann A, Nashan B, Schmidt HH, Böker KH, Emmanouilidis N, Rosenau J, Bahr MJ, Hoffmann MW, Manns MP, Klempnauer J, Schlitt HJ. Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil.  Transplantation  2000;69;9  Link to Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil.
  469. Journal Article Czaja AJ, Manns MP, McFarlane IG, Hoofnagle JH. Autoimmune hepatitis: the investigational and clinical challenges.  Hepatology  2000;31;5  Link to Autoimmune hepatitis: the investigational and clinical challenges.
  470. Journal ArticleReview Obermayer-Straub P, Strassburg CP, Manns MP. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.  Can. J. Gastroenterol.  2000;14;5  Link to Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.
  471. English AbstractJournal ArticleReview Jaeckel E, Manns MP. [The course and therapy of acute hepatitis C viral infection. Is a prevention of its becoming chronic possible?]  Z Gastroenterol  2000;38;5  Link to [The course and therapy of acute hepatitis C viral infection. Is a prevention of its becoming chronic possible?]
  472. Journal Article Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, Miller JL, Manns MP, Rehermann B. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.  Nat. Med.  2000;6;5  Link to Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.
  473. CongressesReview Manns MP. HCV, HDV and autoimmunity.  Acta Gastroenterol. Belg.  2000;63;2  Link to HCV, HDV and autoimmunity.
  474. Case ReportsJournal Article Gölkel C, Widjaja A, Hiller W, Flemming P, Wagner S, Manns MP. Malignant peritoneal mesothelioma with mimicry of pseudomyxoma peritonei in a patient with a history of perforated sigmadiverticulitis.  Z Gastroenterol  2000;38;4  Link to Malignant peritoneal mesothelioma with mimicry of pseudomyxoma peritonei in a patient with a history of perforated sigmadiverticulitis.
  475. Comparative StudyJournal Article Bock CT, Malek NP, Tillmann HL, Manns MP, Trautwein C. The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro.  J. Virol.  2000;74;5  Link to The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro.
  476. CommentLetter Manns MP. Hepatitis C and autoimmune hepatitis.  Hepatology  2000;31;3  Link to Hepatitis C and autoimmune hepatitis.
  477. Case ReportsEnglish AbstractJournal Article Widjaja A, Gebel M, Bleck JS, Walter B, Mix H, Boozari B, Göke M, Manns MP. [Sonographic diagnosis of an unusual recurrence of Chilaiditi syndrome after hemicolectomy]  Ultraschall Med  2000;21;1  Link to [Sonographic diagnosis of an unusual recurrence of Chilaiditi syndrome after hemicolectomy]
  478. Journal Article Plümpe J, Malek NP, Bock CT, Rakemann T, Manns MP, Trautwein C. NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration.  Am. J. Physiol. Gastrointest. Liver Physiol.  2000;278;1  Link to NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration.
  479. Journal ArticleReview Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis.  J. Hepatol.  2000;32;1 Suppl  Link to Autoimmune hepatitis.
  480. Journal ArticleReview Ott M, Schmidt HH, Cichon G, Manns MP. Emerging therapies in hepatology: liver-directed gene transfer and hepatocyte transplantation.  Cells Tissues Organs (Print)  2000;167;2-3  Link to Emerging therapies in hepatology: liver-directed gene transfer and hepatocyte transplantation.
  481. Journal Article Ockenga J, Jacobs R, Kemper A, Benschop RJ, Schmidt RE, Manns MP. Lymphocyte subsets and cellular immunity in patients with chronic pancreatitis.  Digestion  2000;62;1  Link to Lymphocyte subsets and cellular immunity in patients with chronic pancreatitis.
  482. Case ReportsJournal Article Widjaja A, Mix H, Gölkel C, Flemming P, Egensperger R, Holstein A, Rademaker J, Becker H, Hundt M, Wagner S, Manns MP. Uncommon metastasis of a glioblastoma multiforme in liver and spleen.  Digestion  2000;61;3  Link to Uncommon metastasis of a glioblastoma multiforme in liver and spleen.
  483. Journal ArticleReview Bleck JS, Gebel M, Manns MP. [Quantitative sonography. Clinical role and perspectives]  Internist (Berl)  2000;41;1  Link to [Quantitative sonography. Clinical role and perspectives]
  484. Journal Article Lorentz A, Schwengberg S, Sellge G, Manns MP, Bischoff SC. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4.  J. Immunol.  2000;164;1  Link to Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4.

    485. 1999

  485. Case ReportsJournal Article Widjaja A, Rosenthal H, Bleck J, Walter B, Gölkel C, Rademaker J, Holstein A, Gebel M, Manns MP. Pitfall: a pseudo tumor within the left liver lobe presenting with abdominal pain, jaundice and severe weight loss.  Ultraschall Med  1999;20;6  Link to Pitfall: a pseudo tumor within the left liver lobe presenting with abdominal pain, jaundice and severe weight loss.
  486. Case ReportsEnglish AbstractJournal Article Caselitz M, Gebel M, Wagner S, Ockenga J, Lange P, Bleck JS, Ostertag H, Manns MP. [Treatment of multilocular hepatocellular carcinoma (HCC) of 4.5 cm and 3.5 cm diameter using percutaneous ethanol injection in a patient with advanced liver cirrhosis]  Z Gastroenterol  1999;37;12  Link to [Treatment of multilocular hepatocellular carcinoma (HCC) of 4.5 cm and 3.5 cm diameter using percutaneous ethanol injection in a patient with advanced liver cirrhosis]
  487. Journal ArticleReview Bahr MJ, Manns MP. [Liver cirrhosis]  Internist (Berl)  1999;40;12  Link to [Liver cirrhosis]
  488. Journal ArticleReview Böker KH, Manns MP. [Therapy of chronic viral hepatitis]  Internist (Berl)  1999;40;12  Link to [Therapy of chronic viral hepatitis]
  489. Journal Article Bischoff SC, Mayer J, Nguyen QT, Stolte M, Manns MP. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.  Am. J. Gastroenterol.  1999;94;12  Link to Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
  490. Clinical TrialJournal Article Wedemeyer H, Böker KH, Pethig K, Petzold DR, Flemming P, Tillmann HL, Vollmar J, Bastürk M, Goldmann E, Griffin KE, Haverich A, Manns MP. Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial.  Transplantation  1999;68;10  Link to Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial.
  491. Journal Article Trautwein C, Will M, Kubicka S, Rakemann T, Flemming P, Manns MP. 2-acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of cyclin E expression.  Oncogene  1999;18;47  Link to 2-acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of cyclin E expression.
  492. GuidelineJournal ArticlePractice Guideline Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Büschenfelde KH, Zeniya M. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.  J. Hepatol.  1999;31;5  Link to International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.
  493. Journal Article Rudolph KL, Trautwein C, Kubicka S, Rakemann T, Bahr MJ, Sedlaczek N, Schuppan D, Manns MP. Differential regulation of extracellular matrix synthesis during liver regeneration after partial hepatectomy in rats.  Hepatology  1999;30;5  Link to Differential regulation of extracellular matrix synthesis during liver regeneration after partial hepatectomy in rats.
  494. Journal ArticleReview Tillmann HL, Jäckel E, Manns MP. Liver transplantation in autoimmune liver disease--selection of patients.  Hepatogastroenterology  1999;46;30  Link to Liver transplantation in autoimmune liver disease--selection of patients.
  495. Journal ArticleReview Manns MP, Schüler A. [Travel and hepatitis]  Internist (Berl)  1999;40;11  Link to [Travel and hepatitis]
  496. Case ReportsJournal Article Mix H, Wagner S, Böker K, Gloger S, Oldhafer KJ, Behrend M, Flemming P, Manns MP. Subacute liver failure induced by phenprocoumon treatment.  Digestion  1999;60;6  Link to Subacute liver failure induced by phenprocoumon treatment.
  497. Case ReportsJournal Article Strassburg CP, Manns MP. Antinuclear antibody (ANA) patterns in hepatic and extrahepatic autoimmune disease.  J. Hepatol.  1999;31;4  Link to Antinuclear antibody (ANA) patterns in hepatic and extrahepatic autoimmune disease.
  498. Journal Article Cichon G, Schmidt HH, Benhidjeb T, Löser P, Ziemer S, Haas R, Grewe N, Schnieders F, Heeren J, Manns MP, Schlag PM, Strauss M. Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits.  J Gene Med  1999;1;5  Link to Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits.
  499. CommentEditorial Manns MP, Jaeckel E. Searching for the needle in the haystack: another candidate needle in autoimmune hepatitis?  Gastroenterology  1999;117;3  Link to Searching for the needle in the haystack: another candidate needle in autoimmune hepatitis?
  500. Journal Article Bock CT, Tillmann HL, Manns MP, Trautwein C. The pre-S region determines the intracellular localization and appearance of hepatitis B virus.  Hepatology  1999;30;2  Link to The pre-S region determines the intracellular localization and appearance of hepatitis B virus.
  501. Case ReportsJournal Article Widjaja A, Mix H, Wagner S, Graz KF, van den Hoff J, Petrich T, Meier PN, Manns MP. Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis.  Z Gastroenterol  1999;37;8  Link to Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis.
  502. Letter Mix H, Manns MP, Wagner S, Widjaja A, Brabant G. Expression of leptin and its receptor in the human stomach.  Gastroenterology  1999;117;2  Link to Expression of leptin and its receptor in the human stomach.
  503. Journal Article Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP. IL-4 enhances proliferation and mediator release in mature human mast cells.  Proc. Natl. Acad. Sci. U.S.A.  1999;96;14  Link to IL-4 enhances proliferation and mediator release in mature human mast cells.
  504. Case ReportsJournal Article Lohse AW, Obermayer-Straub P, Gerken G, Brunner S, Altes U, Dienes HP, Manns MP, Meyer zum Büschenfelde KH. Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease -- possible association with a steroid-resistant transplant rejection episode.  J. Hepatol.  1999;31;1  Link to Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease -- possible association with a steroid-resistant transplant rejection episode.
  505. Journal ArticleReview Jaeckel E, Tillmann HL, Manns MP. Liver transplantation and autoimmunity.  Acta Gastroenterol. Belg.  1999;62;3  Link to Liver transplantation and autoimmunity.
  506. Journal Article Tillmann HL, Trautwein C, Bock T, Böker KH, Jäckel E, Glowienka M, Oldhafer K, Bruns I, Gauthier J, Condreay LD, Raab HR, Manns MP. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.  Hepatology  1999;30;1  Link to Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
  507. Case ReportsJournal Article Widjaja A, Wagner S, Mix H, Rifai K, Rambusch E, Stolte M, Meier PN, Nashan B, Reimann J, Böker K, Heil G, Manns MP. Malabsorption with progressive weight loss and multiple intestinal ulcers in a patient with T-cell lymphoma.  Z Gastroenterol  1999;37;7  Link to Malabsorption with progressive weight loss and multiple intestinal ulcers in a patient with T-cell lymphoma.
  508. Case ReportsJournal Article Widjaja A, Walter B, Bleck JS, Boozari B, Ockenga J, Holstein A, Göke M, Gebel M, Manns MP. Diagnosis of Chilaiditi's syndrome with abdominal ultrasound.  Z Gastroenterol  1999;37;7  Link to Diagnosis of Chilaiditi's syndrome with abdominal ultrasound.
  509. Journal Article Leifeld L, Trautwein C, Dumoulin FL, Manns MP, Sauerbruch T, Spengler U. Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.  Am. J. Pathol.  1999;154;6  Link to Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.
  510. Journal ArticleReview Strassburg CP, Jaeckel E, Manns MP. Anti-mitochondrial antibodies and other immunological tests in primary biliary cirrhosis.  Eur J Gastroenterol Hepatol  1999;11;6  Link to Anti-mitochondrial antibodies and other immunological tests in primary biliary cirrhosis.
  511. Journal Article Rambusch EG, Manns MP. [Diagnosis of autoimmune hepatitis]  Med. Klin. (Munich)  1999;94;5  Link to [Diagnosis of autoimmune hepatitis]
  512. Journal ArticleReview Schmidt HH, Pröpsting MJ, Manns MP. [Hereditary amyloidosis]  Internist (Berl)  1999;40;5  Link to [Hereditary amyloidosis]
  513. Journal ArticleReview Plümpe J, Streetz K, Manns MP, Trautwein C. Tumour necrosis factor alpha--mediator of apoptosis and cell proliferation of hepatocytes.  Ital J Gastroenterol Hepatol  1999;31;3  Link to Tumour necrosis factor alpha--mediator of apoptosis and cell proliferation of hepatocytes.
  514. Journal Article Bock CT, Kubicka S, Manns MP, Trautwein C. Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor.  Hepatology  1999;29;4  Link to Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor.
  515. Journal Article Dalekos GN, Wedemeyer H, Obermayer-Straub P, Kayser A, Barut A, Frank H, Manns MP. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.  J. Hepatol.  1999;30;3  Link to Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.
  516. English AbstractJournal ArticleReview Trautwein C, Manns MP. [Chronic viral hepatitis--diagnosis, therapy and prognosis]  Versicherungsmedizin  1999;51;1  Link to [Chronic viral hepatitis--diagnosis, therapy and prognosis]
  517. Journal Article Schmidt HH, Nashan B, Pröpsting MJ, Nakazato M, Flemming P, Kubicka S, Böker K, Pichlmayr R, Manns MP. Familial Amyloidotic Polyneuropathy: domino liver transplantation.  J. Hepatol.  1999;30;2  Link to Familial Amyloidotic Polyneuropathy: domino liver transplantation.
  518. Journal Article Schöfl C, Ponczek M, Mader T, Waring M, Benecke H, von zur Mühlen A, Mix H, Cornberg M, Böker KH, Manns MP, Wagner S. Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes.  Am. J. Physiol.  1999;276;1 Pt 1  Link to Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes.
  519. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Strassburg CP, Nguyen N, Manns MP, Tukey RH. UDP-glucuronosyltransferase activity in human liver and colon.  Gastroenterology  1999;116;1  Link to UDP-glucuronosyltransferase activity in human liver and colon.
  520. Journal Article Schmidt HH, Behrens G, Genschel J, Stoll M, Dejam A, Haas R, Manns MP, Schmidt RE. Lipid evaluation in HIV-1-positive patients treated with protease inhibitors.  Antivir. Ther. (Lond.)  1999;4;3  Link to Lipid evaluation in HIV-1-positive patients treated with protease inhibitors.
  521. Journal ArticleReview Manns MP, Rambusch EG. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.  J. Hepatol.  1999;31 Suppl 1  Link to Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.
  522. Journal Article Schlitt HJ, Neipp M, Weimann A, Oldhafer KJ, Schmoll E, Boeker K, Nashan B, Kubicka S, Maschek H, Tusch G, Raab R, Ringe B, Manns MP, Pichlmayr R. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.  J. Clin. Oncol.  1999;17;1  Link to Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.

    523. 1998

  523. Editorial Wedemeyer H, Caselmann WH, Manns MP. Combination therapy of chronic hepatitis C: an important step but not the final goal!  J. Hepatol.  1998;29;6  Link to Combination therapy of chronic hepatitis C: an important step but not the final goal!
  524. English AbstractJournal Article Rambusch EG, Nashan B, Tillmann HL, Böker KH, Schlitt HJ, Maschek H, Raab R, Manns MP. [De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates]  Z Gastroenterol  1998;36;12  Link to [De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates]
  525. Case ReportsJournal Article Oldhafer KJ, Chavan A, Frühauf NR, Flemming P, Schlitt HJ, Kubicka S, Nashan B, Weimann A, Raab R, Manns MP, Galanski M. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?  J. Hepatol.  1998;29;6  Link to Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?
  526. Journal Article Wedemeyer H, Pethig K, Wagner D, Flemming P, Oppelt P, Petzold DR, Haverich A, Manns MP, Boeker KH. Long-term outcome of chronic hepatitis B in heart transplant recipients.  Transplantation  1998;66;10  Link to Long-term outcome of chronic hepatitis B in heart transplant recipients.
  527. Journal Article Wagner S, Enss ML, Cornberg M, Mix H, Schumann S, Kirchner G, Jähne J, Manns MP, Beil W. Morphological and molecular characterization of human gastric mucous cells in long-term primary culture.  Pflugers Arch.  1998;436;6  Link to Morphological and molecular characterization of human gastric mucous cells in long-term primary culture.
  528. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial Ascione A, De Luca M, Canestrini C, Di Costanzo GG, Raimondo G, Longo G, Manns MP, Tillmann HL, Forte GB, Rocco P, Biceglia O, Faleo D, Vinelli F, Cela EM, Amitrano L, Addario L, Gigliotti T. Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study.  Ital J Gastroenterol Hepatol  1998;30;5  Link to Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study.
  529. English AbstractJournal ArticleReview Wedemeyer H, Jäckel E, Wedemeyer J, Frank H, Schüler A, Trautwein C, Manns MP. [Is combination therapy of chronic hepatitis C with interferon alpha and ribavirin in primary interferon nonresponders indicated?--An analysis of personal experiences and review of the literature]  Z Gastroenterol  1998;36;9  Link to [Is combination therapy of chronic hepatitis C with interferon alpha and ribavirin in primary interferon nonresponders indicated?--An analysis of personal experiences and review of the literature]
  530. Journal ArticleReview Bradham CA, Plümpe J, Manns MP, Brenner DA, Trautwein C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury.  Am. J. Physiol.  1998;275;3 Pt 1  Link to Mechanisms of hepatic toxicity. I. TNF-induced liver injury.
  531. Journal Article Tillmann HL, Heringlake S, Trautwein C, Meissner D, Nashan B, Schlitt HJ, Kratochvil J, Hunt J, Qiu X, Lou SC, Pichlmayr R, Manns MP. Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection.  Hepatology  1998;28;2  Link to Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection.
  532. Journal Article Wedemeyer H, Ockenga J, Frank H, Tillmann HL, Schuler A, Caselitz M, Gebel M, Trautwein C, Manns MP. Perihepatic lymphadenopathy: a marker of response to interferon alpha in chronic hepatitis C.  Hepatogastroenterology  1998;45;22  Link to Perihepatic lymphadenopathy: a marker of response to interferon alpha in chronic hepatitis C.
  533. Journal Article Heringlake S, Ockenga J, Tillmann HL, Trautwein C, Meissner D, Stoll M, Hunt J, Jou C, Solomon N, Schmidt RE, Manns MP. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients?  J. Infect. Dis.  1998;177;6  Link to GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients?
  534. Journal Article Trautwein C, Rakemann T, Brenner DA, Streetz K, Licato L, Manns MP, Tiegs G. Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice.  Gastroenterology  1998;114;5  Link to Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice.
  535. Journal Article Trautwein C, Rakemann T, Malek NP, Plümpe J, Tiegs G, Manns MP. Concanavalin A-induced liver injury triggers hepatocyte proliferation.  J. Clin. Invest.  1998;101;9  Link to Concanavalin A-induced liver injury triggers hepatocyte proliferation.
  536. Journal Article Luettig B, Boeker KH, Schoessler W, Will H, Loges S, Schmidt E, Worman HJ, Gershwin ME, Manns MP. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.  J. Hepatol.  1998;28;5  Link to The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
  537. Case ReportsJournal Article Tietge UJ, Schmidt HH, Jäckel E, Trautwein C, Manns MP. Low molecular weight heparin-induced skin necrosis occurring distant from injection sites and without thrombocytopenia.  J. Intern. Med.  1998;243;4  Link to Low molecular weight heparin-induced skin necrosis occurring distant from injection sites and without thrombocytopenia.
  538. Journal ArticleReview Wanger S, Meier PN, Maschek H, Nashan B, Manns MP. [State-of-the-art therapy for primary sclerosing cholangitis]  Dtsch. Med. Wochenschr.  1998;123;11  Link to [State-of-the-art therapy for primary sclerosing cholangitis]
  539. Journal ArticleReview Wagner S, Maschek H, Meier PN, Nashan B, Manns MP. [The current diagnosis of primary sclerosing cholangitis]  Dtsch. Med. Wochenschr.  1998;123;10  Link to [The current diagnosis of primary sclerosing cholangitis]
  540. English AbstractJournal ArticleReview Rambusch EG, Wedemeyer H, Tillmann HL, Heringlake S, Manns MP. [Significance of coinfection with hepatitis G virus for chronic hepatitis C--a review of the literature]  Z Gastroenterol  1998;36;1  Link to [Significance of coinfection with hepatitis G virus for chronic hepatitis C--a review of the literature]
  541. Journal ArticleReview Malek NP, Pluempe J, Kubicka S, Manns MP, Trautwein C. Molecular mechanisms of TNF receptor-mediated signaling.  Recent Results Cancer Res.  1998;147  Link to Molecular mechanisms of TNF receptor-mediated signaling.
  542. Case ReportsJournal Article Klugewitz K, Rehermann B, Seifert U, Böker KH, Stolte M, Meier PN, Wagner S, Manns MP. A rare case of bloody diarrhea: thrombosis of the V. mesenterica inferior following laparoscopic cholecystectomy.  Z Gastroenterol  1998;36;1  Link to A rare case of bloody diarrhea: thrombosis of the V. mesenterica inferior following laparoscopic cholecystectomy.

    543. 1997

  543. Journal Article Bock CT, Tillmann HL, Maschek HJ, Manns MP, Trautwein C. A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly.  Gastroenterology  1997;113;6  Link to A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly.
  544. Journal Article Wagner S, Beil W, Westermann J, Logan RP, Bock CT, Trautwein C, Bleck JS, Manns MP. Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis.  Gastroenterology  1997;113;6  Link to Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis.
  545. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Strassburg CP, Manns MP, Tukey RH. Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer.  Cancer Res.  1997;57;14  Link to Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer.
  546. Case ReportsEnglish AbstractJournal Article Rehermann B, Klugewitz K, Seifert U, Böker KH, Wagner S, Manns MP. [Rare initial manifestation and differential diagnosis of primary sclerosing cholangitis]  Med. Klin. (Munich)  1997;92;7  Link to [Rare initial manifestation and differential diagnosis of primary sclerosing cholangitis]
  547. Journal Article Ockenga J, Tillmann HL, Trautwein C, Stoll M, Manns MP, Schmidt RE. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value.  J. Hepatol.  1997;27;1  Link to Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value.
  548. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Clemente MG, Obermayer-Straub P, Meloni A, Strassburg CP, Arangino V, Tukey RH, De Virgiliis S, Manns MP. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.  J. Clin. Endocrinol. Metab.  1997;82;5  Link to Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.
  549. Journal ArticleReview Trautwein C, Manns MP. [Chronic hepatitis]  Internist (Berl)  1997;38;3  Link to [Chronic hepatitis]
  550. Case ReportsJournal Article Tillmann HL, van Pelt FN, Martz W, Luecke T, Welp H, Dörries F, Veuskens A, Fischer M, Manns MP. Accidental intoxication with methylene dianiline p,p'-diaminodiphenylmethane: acute liver damage after presumed ecstasy consumption.  J. Toxicol. Clin. Toxicol.  1997;35;1  Link to Accidental intoxication with methylene dianiline p,p'-diaminodiphenylmethane: acute liver damage after presumed ecstasy consumption.
  551. Journal Article Böker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, Oldhaver K, Bode U, Pichlmayr R, Manns MP. Long-term outcome of hepatitis C virus infection after liver transplantation.  Hepatology  1997;25;1  Link to Long-term outcome of hepatitis C virus infection after liver transplantation.
  552. Journal Article Trautwein C, Rakemann T, Obermayer-Straub P, Niehof M, Manns MP. Differences in the regulation of cytochrome P450 family members during liver regeneration.  J. Hepatol.  1997;26;1  Link to Differences in the regulation of cytochrome P450 family members during liver regeneration.

    553. 1996

  553. Journal Article Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Böker K, Muerhoff S, Mushahwar IK, Hunsmann G, Manns MP. Association between fulminant hepatic failure and a strain of GBV virus C.  Lancet  1996;348;9042  Link to Association between fulminant hepatic failure and a strain of GBV virus C.
  554. Journal Article Strassburg CP, Alex B, Zindy F, Gerken G, Lüttig B, Meyer zum Büschenfelde KH, Bréchot C, Manns MP. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.  J. Hepatol.  1996;25;6  Link to Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
  555. Journal Article Chen DF, Endres W, Kliem V, Tillmann HL, Brunkhorst R, Koch KM, Manns MP, Stangel W. No significant influence of HLA determinants on susceptibility to hepatitis C virus infection in Caucasian patients with end-stage renal disease.  Liver  1996;16;6  Link to No significant influence of HLA determinants on susceptibility to hepatitis C virus infection in Caucasian patients with end-stage renal disease.
  556. Journal ArticleReview Tillmann HL, Manns MP. Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.  Dig. Dis. Sci.  1996;41;12 Suppl  Link to Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.
  557. Comparative StudyJournal Article Heringlake S, Tillmann HL, Cordes-Temme P, Trautwein C, Hunsmann G, Manns MP. GBV-C/HGV is not the major cause of autoimmune hepatitis.  J. Hepatol.  1996;25;6  Link to GBV-C/HGV is not the major cause of autoimmune hepatitis.
  558. Case ReportsJournal Article Mertens T, Köck J, Hampl W, Schlicht HJ, Tillmann HL, Oldhafer KJ, Manns MP, Arnold R. Reactivated fulminant hepatitis B virus replication after bone marrow transplantation: clinical course and possible treatment with ganciclovir.  J. Hepatol.  1996;25;6  Link to Reactivated fulminant hepatitis B virus replication after bone marrow transplantation: clinical course and possible treatment with ganciclovir.
  559. Comparative StudyJournal Article Chen DF, Kliem V, Endres W, Brunkhorst R, Tillmann HL, Koch KM, Manns MP, Stangel W. Relationship between human leukocyte antigen determinants and courses of hepatitis B virus infection in Caucasian patients with end-stage renal disease.  Scand. J. Gastroenterol.  1996;31;12  Link to Relationship between human leukocyte antigen determinants and courses of hepatitis B virus infection in Caucasian patients with end-stage renal disease.
  560. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Strassburg CP, Obermayer-Straub P, Alex B, Durazzo M, Rizzetto M, Tukey RH, Manns MP. Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis.  Gastroenterology  1996;111;6  Link to Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis.
  561. Journal Article Kliem V, van den Hoff U, Brunkhorst R, Tillmann HL, Flik J, Manns MP, Pichlmayr R, Koch KM, Frei U. The long-term course of hepatitis C after kidney transplantation.  Transplantation  1996;62;10  Link to The long-term course of hepatitis C after kidney transplantation.
  562. Case ReportsJournal Article Malek NP, Ocran K, Tietge UJ, Maschek H, Gratz KF, Trautwein C, Wagner S, Manns MP. A case of the yellow nail syndrome associated with massive chylous ascites, pleural and pericardial effusions.  Z Gastroenterol  1996;34;11  Link to A case of the yellow nail syndrome associated with massive chylous ascites, pleural and pericardial effusions.
  563. Journal Article Trautwein C, Schrem H, Tillmann HL, Kubicka S, Walker D, Böker KH, Maschek HJ, Pichlmayr R, Manns MP. Hepatitis B virus mutations in the pre-S genome before and after liver transplantation.  Hepatology  1996;24;3  Link to Hepatitis B virus mutations in the pre-S genome before and after liver transplantation.
  564. Journal Article Wagner S, Gebel M, Meier P, Trautwein C, Bleck J, Nashan B, Manns MP. Endoscopic management of biliary tract strictures in primary sclerosing cholangitis.  Endoscopy  1996;28;7  Link to Endoscopic management of biliary tract strictures in primary sclerosing cholangitis.
  565. Journal Article Carman WF, Trautwein C, van Deursen FJ, Colman K, Dornan E, McIntyre G, Waters J, Kliem V, Müller R, Thomas HC, Manns MP. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis.  Hepatology  1996;24;3  Link to Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis.
  566. Journal ArticleReview Heringlake S, Tillmann HL, Manns MP. New hepatitis viruses.  J. Hepatol.  1996;25;2  Link to New hepatitis viruses.
  567. Clinical TrialJournal Article Krüger M, Tillmann HL, Trautwein C, Bode U, Oldhafer K, Maschek H, Böker KH, Broelsch CE, Pichlmayr R, Manns MP. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.  Liver Transpl Surg  1996;2;4  Link to Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.
  568. English AbstractJournal Article Niesert S, Messner U, Tillmann HL, Günter HH, Schneider J, Manns MP. [Prevalence of hepatitis B in pregnancy and selective screening]  Geburtshilfe Frauenheilkd  1996;56;6  Link to [Prevalence of hepatitis B in pregnancy and selective screening]
  569. Journal Article Trautwein C, Rakemann T, Niehof M, Rose-John S, Manns MP. Acute-phase response factor, increased binding, and target gene transcription during liver regeneration.  Gastroenterology  1996;110;6  Link to Acute-phase response factor, increased binding, and target gene transcription during liver regeneration.
  570. Case ReportsJournal Article Strassburg CP, Bleck JS, Rosenthal H, Meyer HJ, Gebel M, Manns MP. Diarrhea, massive ascites, and portal hypertension: rare case of a splenic arterio-venous fistula.  Z Gastroenterol  1996;34;4  Link to Diarrhea, massive ascites, and portal hypertension: rare case of a splenic arterio-venous fistula.
  571. Journal ArticleReview Strassburg CP, Obermayer-Straub P, Manns MP. Autoimmunity in hepatitis C and D virus infection.  J. Viral Hepat.  1996;3;2  Link to Autoimmunity in hepatitis C and D virus infection.
  572. Journal Article Rehermann B, Seifert U, Tillmann HL, Michel G, Böker KH, Pichlmayr R, Manns MP. Serological pattern of hepatitis C virus recurrence after liver transplantation.  J. Hepatol.  1996;24;1  Link to Serological pattern of hepatitis C virus recurrence after liver transplantation.
  573. Journal Article Bischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y, Maschek H, Stolte M, Gebel M, Manns MP. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease.  Histopathology  1996;28;1  Link to Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease.

    574. 1995

  574. Journal ArticleReview Strassburg CP, Manns MP. Autoimmune hepatitis versus viral hepatitis C.  Liver  1995;15;5  Link to Autoimmune hepatitis versus viral hepatitis C.
  575. Journal ArticleReview Trautwein C, Manns MP. [Liver diseases in the elderly]  Internist (Berl)  1995;36;7  Link to [Liver diseases in the elderly]
  576. Comparative StudyJournal Article Trautwein C, Kiral G, Tillmann HL, Witteler H, Michel G, Manns MP. Risk factors and prevalence of hepatitis E in German immigrants from the former Soviet Union.  J. Med. Virol.  1995;45;4  Link to Risk factors and prevalence of hepatitis E in German immigrants from the former Soviet Union.
  577. Comparative StudyEnglish AbstractJournal Article Durazzo M, Costa C, Schmidt E, Loges S, Scaglione L, Touscoz AG, Smedile A, Manns MP, Rizzetto M, Pagano G. [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis]  Ann. Ital. Med. Int.  1995;10;2  Link to [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis]
  578. Journal Article Durazzo M, Philipp T, Van Pelt FN, Lüttig B, Borghesio E, Michel G, Schmidt E, Loges S, Rizzetto M, Manns MP. Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection.  Gastroenterology  1995;108;2  Link to Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection.
  579. Journal Article Trautwein C, Davies M, Elias E, Strain A, Manns MP. Extracellular matrix proteins modulate cytochrome P450 2D6 expression in human hepatocytes.  J. Hepatol.  1995;22;1  Link to Extracellular matrix proteins modulate cytochrome P450 2D6 expression in human hepatocytes.

    580. 1994

  580. Journal ArticleReview Trautwein C, Böker K, Manns MP. Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms.  Gut  1994;35;9  Link to Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms.
  581. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Philipp T, Durazzo M, Trautwein C, Alex B, Straub P, Lamb JG, Johnson EF, Tukey RH, Manns MP. Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D.  Lancet  1994;344;8922  Link to Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D.
  582. Journal Article Rehermann B, Schneider A, Michel G, Braun HB, Manns MP. GOR-antibodies in patients with chronic liver disease and hepatocellular carcinoma.  Z Gastroenterol  1994;32;7  Link to GOR-antibodies in patients with chronic liver disease and hepatocellular carcinoma.
  583. Journal Article Michitaka K, Durazzo M, Tillmann HL, Walker D, Philipp T, Manns MP. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2.  Gastroenterology  1994;106;6  Link to Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2.
  584. Journal ArticleReview Rehermann B, Michitaka K, Durazzo M, Mergener K, Velev P, Manns MP. Viruses and auto-immune hepatitis.  Eur. J. Clin. Invest.  1994;24;1  Link to Viruses and auto-immune hepatitis.

    585. 1993

  585. Journal ArticleReview Böker KH, Manns MP. [Inhibition of the progression of chronic liver diseases]  Internist (Berl)  1993;34;4  Link to [Inhibition of the progression of chronic liver diseases]
  586. Journal ArticleReview Manns MP. Viruses and autoimmune liver disease.  Intervirology  1993;35;1-4  Link to Viruses and autoimmune liver disease.

    587. 1992

  587. Journal Article Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis.  Gastroenterology  1992;103;4  Link to Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis.
  588. Journal ArticleReview Rehermann B, Trautwein C, Böker KH, Manns MP. Interleukin-6 in liver diseases.  J. Hepatol.  1992;15;3  Link to Interleukin-6 in liver diseases.
  589. Journal ArticleReview Manns MP. Autoimmune diseases of the liver.  Clin. Lab. Med.  1992;12;1  Link to Autoimmune diseases of the liver.
  590. Journal Article Michel G, Ritter A, Gerken G, Meyer zum Büschenfelde KH, Decker R, Manns MP. Anti-GOR and hepatitis C virus in autoimmune liver diseases.  Lancet  1992;339;8788  Link to Anti-GOR and hepatitis C virus in autoimmune liver diseases.

    591. 1991

  591. Journal Article Manns MP, Bremm A, Schneider PM, Notghi A, Gerken G, Prager-Eberle M, Stradmann-Bellinghausen B, Meyer zum Büschenfelde KH, Rittner C. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis.  Gastroenterology  1991;101;5  Link to HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis.
  592. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.  J. Clin. Invest.  1991;88;4  Link to LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.
  593. Case ReportsJournal Article Gerken G, Kremsdorf D, Capel F, Petit MA, Dauguet C, Manns MP, Meyer zum Büschenfelde KH, Brechot C. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection.  Virology  1991;183;2  Link to Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection.
  594. Journal ArticleReview Manns MP. Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance.  Semin. Liver Dis.  1991;11;3  Link to Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance.
  595. Journal ArticleReview Manns MP. [Acute liver failure: definition, etiology, clinical picture and prognosis]  Z Gastroenterol Verh  1991;26  Link to [Acute liver failure: definition, etiology, clinical picture and prognosis]
  596. Journal ArticleReview Manns MP. Cytochrome P450 enzymes as human autoantigens.  Immunol. Res.  1991;10;3-4  Link to Cytochrome P450 enzymes as human autoantigens.

    597. 1990

  597. Journal ArticleReview Manns MP, Meyer zum Büschenfelde KH. Nature of autoantigens and autoantibodies in autoimmune hepatitis.  Springer Semin. Immunopathol.  1990;12;1  Link to Nature of autoantigens and autoantibodies in autoimmune hepatitis.

    598. 1989

  598. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.  J. Clin. Invest.  1989;83;3  Link to Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.

    599. 1988

  599. Journal ArticleReview Manns MP, Nakamura RM. Autoimmune liver diseases.  Clin. Lab. Med.  1988;8;2  Link to Autoimmune liver diseases.
Back to page of Manns, Michael P..

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.